Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3016616	s-dheas	umol/l (umol/l)	2725	3453	0.03%
3016616	s-dheas	— (—)	430	531	100.00%	Distribution not available
3016616	s-dheas	µmol/l (umol/l)	78	88	0.00%
3016616	s-dheas	umol/l____ (umol/l)	29	42	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Polycystic ovarian syndrome, broad definition

634

570

12.44

307.65

1.2

6.76

6.21

umol/l

2.23

608

508

Benign neoplasm of other and unspecified endocrine glands

371

205

19.25

307.65

1.2

1.4

2.67

4.89

umol/l

11.43

343

176

Polycystic ovarian syndrome, consortium definition

1158

1394

4.87

307.65

1.3

6.27

4.77

umol/l

20.77

1077

1240

Hypertrichosis

279

46.24

307.65

1.4

1.1

7.12

6.42

umol/l

0.90

263

Female infertility, associated with anovulation

428

265

17.95

307.65

1.3

1.2

6.31

6.20

umol/l

0.17

410

227

Disorders of other endocrine glands

976

1215

8.19

307.65

1.5

1.2

5.47

5.29

umol/l

0.54

885

1080

Female infertility

618

503

7.62

307.65

1.2

1.3

6.39

5.27

umol/l

6.71

574

445

Hirsutism in women

264

50.70

307.65

1.5

1.1

7.13

6.56

umol/l

0.64

250

Benign neoplasm: Adrenal gland

306

44.43

307.65

1.1

1.5

2.14

4.53

umol/l

5.36

282

Ovarian dysfunction

476

409

13.22

307.65

1.3

1.1

6.88

6.30

umol/l

1.76

454

367

Polycystic ovarian syndrome

448

324

16.38

307.65

1.3

1.1

7.02

6.43

umol/l

1.55

426

290

Exclusions for E4_PCOS_BROAD

409

508

8.41

307.24

1.9

1.3

4.30

5.22

umol/l

3.36

355

448

Amenorrhoea

260

213

13.14

265.36

1.4

1.3

6.07

6.16

umol/l

0.09

242

181

Irregular menses

730

1306

4.28

250.82

1.3

5.89

4.94

umol/l

7.05

677

1160

Endocrine, nutritional and metabolic diseases

849

1023

4.24

247.04

1.4

1.2

5.91

5.78

umol/l

0.32

786

890

Female infertility, cervical, vaginal, other or unspecified origin

419

471

5.83

188.51

1.2

6.30

5.10

umol/l

6.34

384

416

Other disorders of adrenal gland

147

20.09

188.03

2.4

1.7

3.32

5.10

umol/l

2.87

126

Adrenocortical insufficiency

101

25.74

143.43

2.9

1.4

3.00

4.89

umol/l

1.88

Hypopituitarism

145

125

12.10

142.54

1.8

1.4

4.35

4.99

umol/l

0.85

118

107

Disorders of skin appendages

585

1880

3.14

139.55

1.3

6.28

5.38

umol/l

3.92

533

1674

Noninflammatory disorders of female genital tract

489

624

3.99

132.23

1.3

6.44

5.36

umol/l

5.56

455

557

Other nutritional deficiencies

658

2173

2.79

125.48

1.3

5.44

5.22

umol/l

0.69

599

1932

Obesity and other hyperalimentation

624

2111

2.81

120.92

1.3

5.49

5.17

umol/l

1.17

567

1877

Obesity

618

2110

2.79

118.07

1.3

5.52

5.17

umol/l

1.30

562

1876

Oligomenorrhoea

102

15.51

115.21

1.3

1.1

6.61

6.07

umol/l

0.32

Neurotic, stress-related and somatoform disorders

730

2093

2.42

97.84

1.4

1.3

5.43

5.17

umol/l

0.96

647

1866

Anxiety disorders

733

2098

2.41

97.62

1.4

1.3

5.41

5.16

umol/l

0.91

649

1872

Anxiety (asthma-related co-morbidities)

583

1720

2.60

92.85

1.4

1.3

5.62

5.51

umol/l

0.28

513

1533

All anxiety disorders

605

1880

2.52

90.88

1.3

5.64

5.49

umol/l

0.38

535

1680

Anxiety disorders, excluding more controls

622

1586

2.52

89.27

1.4

1.3

5.19

5.22

umol/l

0.05

546

1427

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

313

937

3.38

85.06

1.6

1.3

4.34

4.79

umol/l

1.16

274

839

Obesity due to excess calories

458

1719

2.69

83.32

1.3

5.44

5.25

umol/l

0.44

412

1523

Disorders of the thyroid gland

705

2059

2.23

78.01

1.5

1.2

5.01

5.43

umol/l

1.45

636

1838

Depression

703

2154

2.19

75.15

1.4

1.3

5.10

5.28

umol/l

0.54

620

1922

Hypothyroidism (congenital or acquired)

318

520

3.47

75.01

1.4

1.2

5.92

6.48

umol/l

1.47

295

465

Excessive, frequent and irregular menstruation

362

615

3.18

73.76

1.3

6.05

5.42

umol/l

1.97

334

548

Mood disorders, excluding more controls

626

1594

2.32

73.74

1.4

1.3

5.00

5.20

umol/l

0.58

554

1431

Hypothyroidism and >3 levothyroxin purchases

314

519

3.44

73.08

1.4

1.2

5.99

6.49

umol/l

1.22

290

464

Hypothyroidism, levothyroxine purchases

314

519

3.44

73.08

1.4

1.2

5.99

6.49

umol/l

1.22

290

464

Hypothyroidism, other/unspecified

662

1972

2.22

72.48

1.5

1.2

4.99

5.41

umol/l

1.36

595

1768

Medical observation and evaluation for suspected diseases and conditions

449

842

2.74

70.80

1.4

1.2

5.27

5.63

umol/l

0.93

397

760

Mood disorders

717

2163

2.13

70.55

1.4

1.3

5.11

5.26

umol/l

0.47

633

1930

Mood [affective] disorders

715

2165

2.13

70.04

1.4

1.3

5.11

5.26

umol/l

0.43

631

1932

Hypothyreosis and Thyroxine purchase for inclusion criteria

676

2055

2.17

69.77

1.5

1.2

4.96

5.35

umol/l

1.24

607

1843

Recurrent or chronic depression

316

703

3.14

69.40

1.4

1.2

5.32

5.67

umol/l

0.65

267

632

Hypogonadotropic hypogonadism

18.26

69.14

1.4

1.2

5.84

5.57

umol/l

0.11

Other anxiety disorders

480

1723

2.39

66.11

1.4

1.3

5.89

5.68

umol/l

0.52

432

1544

Obesity, other/unspecified

330

1201

2.78

63.96

1.4

1.3

5.50

5.21

umol/l

0.67

301

1062

Medical treatment for female infertility

322

1159

2.81

62.81

1.3

5.88

5.57

umol/l

0.92

296

1039

Hyperfunction of pituitary gland

123

7.51

61.26

1.6

1.2

5.21

5.65

umol/l

0.41

110

Headache

526

1846

2.21

59.64

1.4

1.2

4.99

5.54

umol/l

1.62

469

1644

Type 2 diabetes

625

1715

2.12

59.38

1.3

5.09

5.05

umol/l

0.10

574

1507

Type 2 diabetes, definitions combined, including avohilmo

578

1585

2.12

54.87

1.2

1.3

5.11

4.97

umol/l

0.35

533

1391

Other (not insulin) diabetes medications

581

1632

2.10

54.11

1.2

1.3

5.09

4.91

umol/l

0.50

533

1432

Used for control exclusion in common control thyroid runs

707

1824

1.96

52.91

1.5

1.2

5.16

5.63

umol/l

2.18

635

1633

Type 2 diabetes, definitions combined

564

1567

2.10

52.74

1.2

1.3

5.11

4.96

umol/l

0.36

520

1374

Biguanides

557

1605

2.10

52.65

1.3

5.07

4.83

umol/l

0.67

513

1406

Type 2 diabetes, strict (exclude DM1)

565

1574

2.10

52.48

1.2

1.3

5.10

4.95

umol/l

0.38

521

1380

General examination and investigation of persons without complaint and reported diagnosis

397

842

2.46

51.40

1.4

1.2

5.25

5.63

umol/l

0.94

351

760

Pain and other conditions associated with female genital organs and menstrual cycle

213

562

3.21

50.97

1.3

5.93

5.68

umol/l

0.37

195

499

Other antidepressants

610

1537

2.03

50.53

1.4

1.2

5.16

5.45

umol/l

0.91

536

1382

Hypothyroidism, strict autoimmune

515

1606

2.12

50.36

1.4

1.1

5.11

5.60

umol/l

1.36

461

1447

Diabetes mellitus

672

2023

1.93

49.44

1.3

5.05

5.13

umol/l

0.17

614

1778

Pain in joint

403

1078

2.31

47.85

1.4

1.2

5.25

5.53

umol/l

0.66

343

968

Diabetes, varying definitions

662

2017

1.91

47.64

1.3

5.09

5.10

umol/l

0.03

604

1773

Behavioural syndromes associated with physiological disturbances and physical factors

631

2250

1.91

46.68

1.3

5.29

5.25

umol/l

0.08

555

2010

Any mental disorder

631

1626

1.95

46.47

1.4

1.3

4.88

5.15

umol/l

0.87

553

1459

Special screening examination for infectious and parasitic diseases

252

662

2.80

46.26

1.3

1.2

6.01

6.45

umol/l

0.98

219

600

Exclusions for E4_PCOS_CONSORTIUM

605

1969

1.93

45.50

1.5

1.3

4.82

5.46

umol/l

3.51

535

1774

Migraine

474

1796

2.07

45.37

1.5

1.3

5.47

5.66

umol/l

0.49

424

1634

Examination and observation for other reasons

356

841

2.40

44.99

1.3

1.2

5.16

5.63

umol/l

1.20

316

760

Depression medications

285

532

2.72

44.13

1.3

1.2

6.12

6.51

umol/l

0.76

250

472

Diabetes medication

649

2044

1.86

43.35

1.3

5.08

5.05

umol/l

0.07

594

1796

Other endocrine disorders

154

5.46

42.31

1.6

1.5

3.57

5.50

umol/l

4.05

134

Persons encountering health services for other counselling and medical advice, not elsewhere classified

648

1874

1.84

41.10

1.4

1.3

5.19

5.09

umol/l

0.24

577

1660

Hyperprolactinaemia

7.23

40.04

1.4

1.2

5.69

5.37

umol/l

0.25

Diseases of the skin and subcutaneous tissue

593

1588

1.88

39.41

1.4

1.3

5.34

5.16

umol/l

0.47

532

1408

Sleep disorders

578

2180

1.83

38.25

1.3

5.34

5.33

umol/l

0.03

514

1947

Genitourinary diseases

306

636

2.42

38.22

1.3

1.4

5.67

5.11

umol/l

1.36

272

554

General symptoms and signs

671

1889

1.79

37.93

1.4

1.2

4.98

5.50

umol/l

2.72

600

1682

Depression or dysthymia

335

813

2.26

36.88

1.4

1.3

5.09

5.20

umol/l

0.16

288

730

Episodal and paroxysmal disorders

690

2017

1.74

35.99

1.4

1.3

5.37

5.41

umol/l

0.09

610

1830

Insomnia

575

2263

1.77

34.36

1.3

5.32

5.35

umol/l

0.05

514

2019

Hypothyroidism, strict autoimmune, 3 medication purchases required

530

1963

1.82

34.27

1.4

1.2

5.01

5.30

umol/l

0.67

473

1762

Personality disorders, excluding more controls

236

990

2.40

34.23

1.5

1.2

5.15

6.06

umol/l

3.13

212

900

Psychiatric diseases

518

1391

1.87

34.04

1.4

1.3

5.01

5.17

umol/l

0.35

454

1245

Selective serotonin reuptake inhibitors

551

1574

1.83

33.88

1.3

5.31

5.39

umol/l

0.16

479

1413

Sleep apnoea

442

1453

1.92

33.39

1.3

4.23

4.44

umol/l

0.34

368

1292

Persons encountering health services in other circumstances, wide

632

1874

1.74

33.00

1.4

1.3

5.33

5.09

umol/l

0.73

563

1660

Sleep disorders (combined)

634

1928

1.72

32.22

1.3

5.44

5.38

umol/l

0.10

554

1748

Benign neoplasms

634

2015

1.72

32.20

1.4

1.3

4.94

5.91

umol/l

7.39

569

1798

Somatoform disorder

135

444

3.08

31.79

1.6

1.3

4.51

5.35

umol/l

1.80

119

400

Other special examinations and investigations of persons without complaint or reported diagnosis

348

842

2.10

31.62

1.4

1.2

5.23

5.63

umol/l

0.99

308

760

Malignant neoplasm of endocrine gland, including Hilmo

182

4.42

31.57

1.4

3.98

4.53

umol/l

0.52

165

Antihypertensive medication - note that there are other indications

566

1689

1.76

30.89

1.4

1.3

5.96

6.09

umol/l

0.31

506

1528

Sleep apnoea, including avohilmo

494

1660

1.80

30.44

1.3

4.46

4.69

umol/l

0.43

412

1484

Malaise and fatigue

299

1128

2.10

30.09

1.5

1.2

4.35

5.23

umol/l

3.71

261

992

Any gastric operation

554

1592

1.75

29.58

1.4

1.2

5.39

5.97

umol/l

2.67

496

1431

GASTRO-related operations

554

1592

1.75

29.58

1.4

1.2

5.39

5.97

umol/l

2.67

496

1431

Testicular hypofunction

10.89

28.72

1.7

1.1

6.75

4.62

umol/l

1.38

Neurological diseases, wide definition

267

598

2.26

28.69

1.4

1.3

6.12

6.14

umol/l

0.03

237

547

Dentofacial anomalies [including malocclusion]

498

2251

1.74

28.47

1.4

1.3

4.99

5.41

umol/l

1.68

438

2023

Other disorders of fluid, electrolyte and acid-base balance

132

428

2.92

28.23

1.7

1.3

3.20

3.76

umol/l

0.98

119

369

Acne, including avohilmo

313

1274

2.01

28.09

1.2

1.3

6.70

6.26

umol/l

1.25

286

1162

Endometriosis

210

503

2.44

28.02

1.3

4.78

5.10

umol/l

0.52

190

445

Non-invasive ventilation

146

456

2.78

27.94

1.3

2.82

5.51

umol/l

12.34

120

404

L02BG Aromatase inhibitors

152

567

2.66

27.63

1.3

1.4

5.27

3.67

umol/l

5.40

139

513

Obesity related asthma

201

868

2.33

27.52

1.4

1.3

4.33

4.82

umol/l

0.97

172

761

Unspecified/other endometriosis

237

3.69

27.49

1.3

1.2

4.80

5.63

umol/l

1.11

203

Malignant neoplasm of endocrine gland

148

4.53

27.34

1.4

4.17

4.65

umol/l

0.37

133

Testicular dysfunction

9.57

27.12

1.7

1.1

6.75

4.70

umol/l

1.37

Triptan medication for migraine, single purchase ok

522

2087

1.70

26.91

1.4

1.3

5.46

5.44

umol/l

0.04

465

1866

Migraine, single triptan purchase ok & required. ICD-code if available is included

522

2087

1.70

26.91

1.4

1.3

5.46

5.44

umol/l

0.04

465

1866

Procreative management

267

1063

2.08

26.67

1.6

1.3

5.16

5.42

umol/l

0.50

242

935

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

586

2292

1.64

26.37

1.5

1.3

5.23

5.12

umol/l

0.24

516

2056

Autoimmune diseases

660

2086

1.61

25.99

1.4

1.2

5.04

5.52

umol/l

2.20

590

1863

Myalgia

185

805

2.32

24.99

1.6

1.2

4.59

5.59

umol/l

3.24

164

716

Other headache syndromes

272

1376

1.98

24.61

1.4

1.3

4.37

5.26

umol/l

3.92

237

1247

Disorders of adult personality and behaviour

263

1322

2.01

24.58

1.4

1.3

5.37

6.12

umol/l

2.54

235

1196

Generalized anxiety disorder

194

870

2.25

24.40

1.2

1.3

6.06

6.40

umol/l

0.62

175

795

Neurological diseases

552

1679

1.66

24.25

1.4

1.3

5.67

5.57

umol/l

0.22

485

1536

Acute upper respiratory infections of multiple and unspecified sites

476

2071

1.68

24.01

1.3

5.58

5.21

umol/l

0.80

422

1861

Postprocedural endocrine and metabolic disorders, not elsewhere classified

318

3.12

23.75

1.6

1.3

4.24

4.92

umol/l

0.90

280

Other metabolic disorders

105

356

2.98

23.58

1.5

1.3

4.13

4.81

umol/l

1.00

314

Fibromyalgia

277

3.26

23.17

1.4

1.2

3.44

5.33

umol/l

5.89

248

Symptoms and signs involving the digestive system and abdomen

533

1623

1.65

23.13

1.4

1.2

5.04

5.43

umol/l

1.37

469

1445

Benzodiazepine use

559

2362

1.60

22.96

1.4

1.3

4.73

5.27

umol/l

2.78

496

2105

Nonorganic sleeping disorders, excluding more controls

166

717

2.33

22.87

1.4

1.3

5.41

5.87

umol/l

0.74

145

651

Neoplasms

555

1801

1.62

22.76

1.4

1.3

5.60

6.11

umol/l

2.26

498

1612

Other reaction to severe stress, and adjustment disorders

282

1501

1.89

22.20

1.4

1.3

5.15

5.58

umol/l

1.16

255

1341

Dorsalgia

596

2004

1.58

22.05

1.3

5.20

5.61

umol/l

1.59

524

1800

Acute upper respiratory infections

572

2169

1.58

21.99

1.3

5.39

5.08

umol/l

0.72

500

1945

Hypothyroidism, drug reimbursement

100

229

3.07

21.63

1.6

1.1

4.74

5.82

umol/l

1.79

201

Abdominal and pelvic pain

524

1623

1.63

21.51

1.4

1.2

5.10

5.43

umol/l

1.07

469

1445

Symptoms and signs involving the circulatory and respiratory systems

619

1995

1.56

21.38

1.4

1.3

5.04

5.59

umol/l

2.96

547

1805

Personality disorders

236

1204

1.98

21.23

1.5

1.3

5.15

6.04

umol/l

3.14

212

1086

Opioids

591

1949

1.57

21.20

1.4

1.2

5.11

5.75

umol/l

3.38

525

1761

Dysplasia of cervi uteri

150

436

2.44

21.10

1.3

1.2

5.69

5.07

umol/l

1.07

135

385

Other soft tissue disorders, not elsewhere classified

569

2068

1.57

20.80

1.5

1.3

4.66

5.63

umol/l

7.52

512

1852

Caries of dentine

122

459

2.58

20.80

1.5

1.4

4.26

5.04

umol/l

1.69

106

390

Ovarian cyst

201

538

2.15

20.17

1.3

4.74

5.30

umol/l

1.14

186

477

Medicines for HER+ breast cancer

171

736

2.17

19.78

1.3

1.4

5.07

3.70

umol/l

4.87

153

656

Parasetamol

452

1391

1.65

19.65

1.3

5.89

5.90

umol/l

0.02

408

1245

Hyperkinetic disorders, excluding more controls

175

773

2.14

19.20

1.3

6.22

6.41

umol/l

0.27

153

708

Adenomyosis (Endometriosis of uterus)

211

3.34

19.14

1.4

1.2

4.16

3.79

umol/l

0.32

189

Chronic diseases of tonsils and adenoids

482

1918

1.59

19.07

1.5

1.3

5.48

5.32

umol/l

0.37

434

1713

Sciatica+with lumbago

257

1230

1.86

18.98

1.6

1.2

4.71

4.99

umol/l

0.30

229

1091

Migraine without aura

217

1123

1.95

18.82

1.7

1.3

5.52

5.99

umol/l

0.92

188

1011

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

137

594

2.32

18.77

1.2

1.3

3.87

4.19

umol/l

0.43

126

505

Glucagon-like peptide-1 (GLP-1) analogues

137

594

2.32

18.77

1.2

1.3

3.87

4.19

umol/l

0.43

126

505

Dental caries

129

512

2.39

18.71

1.5

1.3

4.21

4.92

umol/l

1.55

112

439

Specific personality disorders

209

1071

1.97

18.65

1.4

1.3

5.27

6.09

umol/l

2.41

183

966

Triptan medication for migraine, min. 3 purchases

449

2112

1.60

18.60

1.4

1.3

5.40

5.66

umol/l

0.79

398

1914

Nausea and vomiting

172

800

2.11

18.56

1.5

1.3

4.43

5.51

umol/l

2.90

152

721

Other dorsopathies, not elsewhere classified

588

2011

1.52

18.52

1.3

5.38

5.62

umol/l

0.69

525

1807

Acne

150

680

2.23

18.39

1.2

6.53

6.47

umol/l

0.06

129

615

Endometriosis of pelvic peritoneum

100

342

2.68

18.21

1.2

1.3

4.41

4.79

umol/l

0.41

299

Menorrhagia

171

435

2.20

18.18

1.5

1.3

4.87

4.62

umol/l

0.38

151

386

Intestinal infectious diseases, including avohilmo, including avohilmo

605

2254

1.50

17.95

1.5

1.3

5.11

umol/l

0.00

531

2018

First line medication for Crohn's disease

628

2276

1.49

17.90

1.5

1.2

4.24

5.62

umol/l

15.66

541

2039

Asthma (mode)

406

1298

1.65

17.88

1.4

1.2

4.33

5.25

umol/l

5.16

352

1168

Irritable bowel syndrome

185

923

2.02

17.80

1.4

1.2

4.38

5.50

umol/l

4.42

161

828

Non-selective monoamine reuptake inhibitors

130

541

2.31

17.66

1.6

1.2

3.07

4.00

umol/l

2.23

113

480

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

212

1101

1.91

17.47

1.3

1.2

5.34

6.01

umol/l

1.58

183

996

Asthma

407

1285

1.64

17.47

1.4

1.2

4.32

5.25

umol/l

5.20

352

1158

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

292

1471

1.75

17.43

1.3

6.32

6.42

umol/l

0.16

260

1343

Other functional intestinal disorders

247

1234

1.82

17.40

1.6

1.3

4.30

5.06

umol/l

2.61

225

1096

Symptoms and signs involving the nervous and musculoskeletal systems

298

1743

1.72

17.23

1.5

1.3

4.06

5.07

umol/l

4.95

265

1539

Mycoses, including avohilmo

514

2587

1.52

17.14

1.3

5.05

5.28

umol/l

0.65

457

2307

Dermatitis and eczema

599

2402

1.48

16.98

1.4

1.3

4.84

5.31

umol/l

2.21

527

2142

Tonsillectomy and adenotomy

455

2038

1.56

16.96

1.3

6.02

5.58

umol/l

1.59

411

1811

Asthma, excluding more controls

401

1269

1.63

16.76

1.4

1.2

4.36

5.27

umol/l

4.96

347

1143

Persistent mood disorders

117

499

2.36

16.74

1.2

4.28

5.46

umol/l

3.34

108

449

KRA_PSY_EATING, excluding more controls

128

564

2.29

16.71

1.2

1.3

5.92

6.56

umol/l

1.30

115

525

Endometriosis of ovary

308

2.71

16.56

1.3

1.2

4.66

4.28

umol/l

0.41

274

Other menopausal disorders

116

261

2.49

16.18

1.7

1.2

3.90

3.39

umol/l

0.95

234

Type 2 diabetes, wide definition

266

945

1.78

16.14

1.3

3.87

3.99

umol/l

0.17

236

815

Hypo-osmolality and hyponatraemia

207

3.13

16.11

2.0

1.4

3.11

3.40

umol/l

0.24

177

Abnormalities of breathing

523

1991

1.51

16.09

1.4

1.3

4.63

5.59

umol/l

3.89

454

1803

Polyp of the female genital tract

131

320

2.33

15.96

1.3

1.2

5.22

3.88

umol/l

1.10

116

285

Bronchitis

589

2417

1.46

15.96

1.3

5.34

5.17

umol/l

0.34

524

2155

Certain infectious and parasitic diseases

553

1861

1.49

15.82

1.4

1.3

5.09

5.44

umol/l

1.26

496

1670

Dorsopathies

592

2045

1.47

15.75

1.3

5.37

5.57

umol/l

0.56

530

1836

Codeine

524

1890

1.50

15.74

1.3

1.2

4.87

5.68

umol/l

4.75

466

1706

Disorders of thyroid, IBD co-morbidities

121

358

2.33

15.48

1.5

1.2

4.75

6.16

umol/l

4.04

113

323

Soft tissue disorders

594

2085

1.46

15.48

1.4

1.3

5.21

5.63

umol/l

1.65

531

1867

Gestational diabetes (for exclusion)

378

1645

1.59

15.29

1.2

1.3

6.21

5.76

umol/l

1.50

347

1489

Gastrointestinal diseases

412

1311

1.58

15.28

1.3

5.50

6.09

umol/l

2.48

367

1192

Diseases of the ear and mastoid process

638

2226

1.44

15.25

1.4

1.3

5.01

5.35

umol/l

1.38

561

1990

Other follicular disorders

207

3.08

15.13

1.2

5.22

5.49

umol/l

0.22

185

Disorders of parathyroid gland

234

2.88

14.65

2.4

1.2

3.29

3.17

umol/l

0.11

212

Wide developmental disorders, excluding more controls

166

3.31

14.62

1.5

1.6

6.75

6.10

umol/l

0.46

151

Implicit viral Sepsis

102

436

2.35

14.57

1.6

1.3

3.71

4.92

umol/l

3.21

393

Viral Sepsis

102

436

2.35

14.57

1.6

1.3

3.71

4.92

umol/l

3.21

393

Asthma (only as main-diagnosis)

366

1285

1.60

14.55

1.4

1.2

4.39

5.25

umol/l

4.16

319

1158

Low back pain

437

1946

1.52

14.54

1.3

1.2

4.99

5.61

umol/l

1.47

379

1748

Persons encountering health services in other circumstances

244

1405

1.73

14.48

1.4

1.3

5.11

5.54

umol/l

0.97

219

1251

Care involving use of rehabilitation procedures

311

1731

1.62

14.34

1.5

1.3

3.90

4.92

umol/l

5.15

272

1533

Benign neoplasm of other and ill-defined parts of digestive system

274

2.72

14.28

1.5

1.3

3.13

3.93

umol/l

1.40

238

Implicit viral Sepsis, including avohilmo

142

698

2.04

14.24

1.5

1.3

3.81

4.89

umol/l

3.71

128

615

Asthma (only as main-diagnosis), excluding more controls

364

1269

1.59

14.22

1.4

1.2

4.42

5.27

umol/l

4.10

317

1143

Symptoms and signs involving the skin and subcutaneous tissue

370

2267

1.54

14.04

1.4

1.3

4.29

5.07

umol/l

4.13

327

2016

Spondylosis

171

695

1.93

14.03

1.5

1.3

2.95

3.70

umol/l

2.68

143

604

Other symptoms and signs involving the nervous and musculoskeletal systems

225

1293

1.75

14.01

1.5

1.3

4.00

5.15

umol/l

4.70

201

1142

Post-traumatic stress disorder

113

517

2.22

13.88

1.4

1.2

5.43

6.53

umol/l

2.71

102

473

Cerebral cysts

156

3.32

13.83

1.5

1.2

4.31

6.02

umol/l

2.82

137

Other disorders of lacrimal gland

179

965

1.86

13.81

1.6

1.3

4.00

4.85

umol/l

2.21

159

858

Acne vulgaris

113

518

2.21

13.76

1.3

1.2

6.65

6.54

umol/l

0.11

101

467

Migraine without aura and triptan purchases

177

954

1.87

13.75

1.7

1.3

5.30

6.05

umol/l

1.56

149

861

Oedema, not elsewhere classified

136

653

2.04

13.67

1.6

1.2

4.35

4.72

umol/l

0.58

125

568

Other diseases of upper respiratory tract

548

1977

1.45

13.66

1.4

1.3

5.11

5.23

umol/l

0.26

488

1764

Other problems related to primary support group, including family circumstances

134

641

2.06

13.58

1.6

1.3

5.12

5.91

umol/l

1.47

119

585

Persons encountering health services for examination and investigation

282

842

1.68

13.51

1.4

1.2

5.40

5.63

umol/l

0.38

253

760

Anaemias

154

495

2.00

13.49

1.4

1.3

4.48

6.17

umol/l

7.61

137

442

Abnormalities of heart beat

191

1027

1.81

13.39

1.4

1.3

4.75

5.48

umol/l

1.84

158

920

Lower back pain or/and sciatica

560

2448

1.42

13.30

1.4

1.3

4.83

5.36

umol/l

1.55

489

2195

Other specific joint derangements/joint disorders

475

2021

1.47

13.25

1.4

1.3

5.00

5.76

umol/l

3.93

405

1827

Codeine or tramadol medication

576

2204

1.42

13.22

1.3

4.69

5.49

umol/l

4.96

508

1969

Uterine polyps

114

297

2.25

13.11

1.3

1.2

4.18

3.71

umol/l

0.64

264

Atopic dermatitis

403

2144

1.50

13.08

1.4

1.3

5.14

5.62

umol/l

1.80

359

1927

Vocal cord dysfunction

229

2.70

13.07

1.3

1.4

4.25

4.99

umol/l

0.84

200

Other noninflammatory disorders of vulva and perineum

204

2.92

12.99

1.2

1.3

4.93

4.76

umol/l

0.12

179

Autism spe, excluding more controls

115

3.65

12.74

1.5

6.82

6.50

umol/l

0.17

104

Follow-up examination after treatment for conditions other than malignant neoplasms

204

765

1.78

12.71

1.3

1.2

4.82

5.72

umol/l

2.83

181

694

575

2063

1.42

12.70

1.3

5.24

5.12

umol/l

0.22

505

1845

Intestinal infectious diseases

502

2614

1.43

12.62

1.5

1.3

5.05

5.26

umol/l

0.61

439

2340

Cervicalgia

102

467

2.20

12.46

1.2

1.3

3.55

4.78

umol/l

3.37

416

Pain (limb, back, neck, head abdominally)

342

1096

1.57

12.40

1.4

1.2

5.32

5.50

umol/l

0.33

306

983

Other specified and unspecified personality disorders

278

2.58

12.37

1.5

1.2

4.89

5.73

umol/l

1.23

250

Abnormal findings on examination of blood, without diagnosis

174

867

1.82

12.37

1.4

1.3

3.80

4.50

umol/l

1.86

150

758

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

237

1381

1.66

12.24

1.3

4.69

4.99

umol/l

0.55

206

1224

Implicit Sepsis

321

1522

1.56

12.23

1.4

1.3

3.75

4.91

umol/l

7.00

285

1341

Other diseases of intestines

597

2397

1.39

12.14

1.4

1.3

4.63

5.53

umol/l

7.06

523

2145

Thyroiditis, ILD-related definition

390

2.30

12.14

1.8

1.3

4.28

5.39

umol/l

2.05

350

Benign thyroid growths and nodules

116

522

2.07

12.10

1.4

1.2

3.48

3.81

umol/l

0.49

107

470

Phobic anxiety disorders

132

673

1.97

12.09

1.5

1.3

5.57

6.37

umol/l

1.47

118

612

Metabolic disorders

406

1641

1.49

12.04

1.5

1.3

3.93

4.77

umol/l

4.38

366

1429

Nonorganic sleeping disorders

166

917

1.82

11.96

1.4

1.3

5.41

5.87

umol/l

0.76

145

820

Conjunctivitis

454

2550

1.44

11.86

1.3

4.71

5.41

umol/l

4.16

402

2282

Polyuria

344

2.36

11.83

1.8

1.2

3.84

4.46

umol/l

0.83

307

Diabetes mellitus in pregnancy

342

1425

1.53

11.80

1.3

6.43

5.88

umol/l

1.91

315

1283

Other pulmonary diagnosis

388

1296

1.50

11.70

1.4

1.2

5.13

5.26

umol/l

0.25

341

1166

Diseases of middle ear and mastoid

391

2174

1.47

11.68

1.4

1.3

5.68

5.67

umol/l

0.02

351

1952

Vasomotor and allergic rhinitis

262

1608

1.60

11.68

1.4

1.3

4.93

5.64

umol/l

2.12

230

1439

Tramadol

342

1346

1.53

11.66

1.4

1.3

4.03

5.14

umol/l

2.82

288

1202

Diseases of the eye and adnexa

501

1763

1.43

11.61

1.3

5.48

5.73

umol/l

0.70

449

1582

Inflammatory diseases of female pelvic organs

438

2090

1.44

11.25

1.4

1.3

4.73

5.58

umol/l

5.20

397

1899

Disorders of lacrimal system

204

1195

1.68

11.24

1.5

1.3

4.12

4.75

umol/l

1.56

183

1064

Disorders of conjunctiva

472

2596

1.41

11.16

1.3

4.70

5.36

umol/l

3.97

420

2322

Schizophrenia or delusion, excluding more controls

148

796

1.84

11.13

1.2

5.45

5.58

umol/l

0.14

134

712

Precocious puberty

9.75

11.10

1.6

2.2

4.12

6.16

umol/l

1.14

Other joint disorders

546

2050

1.39

11.10

1.3

5.46

5.74

umol/l

0.87

478

1853

Cystitis

467

1955

1.42

11.08

1.3

5.20

5.34

umol/l

0.34

420

1758

Injuries to the ankle and foot

429

2568

1.43

11.07

1.3

5.46

5.36

umol/l

0.21

386

2288

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

238

1477

1.61

11.07

1.4

1.3

3.61

4.78

umol/l

5.53

210

1295

Temporomandibular joint disorders, including avohilmo

334

2174

1.49

10.97

1.5

1.3

5.10

5.81

umol/l

3.12

294

1964

Excluding asthma or asthma-COPD overlap

383

1296

1.48

10.89

1.4

1.2

5.18

5.26

umol/l

0.13

336

1166

Dissociative [conversion] disorders

159

3.01

10.88

1.3

5.28

6.46

umol/l

1.16

145

COPD differential diagnosis

383

1300

1.48

10.74

1.4

1.2

5.19

5.25

umol/l

0.09

336

1170

ILD differential diagnosis

382

1298

1.48

10.66

1.4

1.2

5.18

5.25

umol/l

0.13

335

1168

Spinal stenosis

123

465

1.95

10.52

1.3

1.2

2.14

3.14

umol/l

4.60

107

400

Panic disorder

133

716

1.87

10.49

1.4

1.3

5.45

6.27

umol/l

1.73

120

651

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

380

1544

1.46

10.44

1.4

1.3

4.07

4.66

umol/l

2.15

342

1343

Asthma, including avohilmo

610

2493

1.35

10.40

1.3

4.66

5.38

umol/l

4.55

530

2235

Diseases of the musculoskeletal system and connective tissue

364

1234

1.48

10.37

1.3

6.02

5.87

umol/l

0.29

321

1121

Diseases of the myoneural junction and muscle

185

2.77

10.36

1.3

3.19

4.37

umol/l

1.58

163

Complications of medical and surgical care

325

1971

1.48

10.33

1.4

1.3

3.68

4.95

umol/l

8.36

291

1742

Soft tissue disorders related to use, overuse and pressure

102

504

2.03

10.30

1.5

1.2

3.36

4.45

umol/l

2.45

445

Hypertension, essential

300

1108

1.53

10.26

1.4

1.3

4.08

4.61

umol/l

1.62

270

964

Dysphagia

425

2.13

10.25

1.4

1.3

3.86

4.39

umol/l

0.75

382

Other intervertebral disc disorders

352

1423

1.48

10.21

1.4

1.2

4.40

5.13

umol/l

1.50

301

1260

Dyspnoea

410

2079

1.43

10.21

1.4

1.3

4.19

5.03

umol/l

2.39

360

1844

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

253

1596

1.56

10.21

1.4

1.3

3.66

4.83

umol/l

6.01

224

1400

Any reimbursement code in KELA

419

1464

1.44

10.20

1.4

1.2

5.65

6.16

umol/l

1.76

379

1315

Other noninflammatory disorders of uterus, except cervix

195

2.44

10.19

1.4

1.2

4.22

2.83

umol/l

2.07

178

Other/unspecified dorsalgia

178

1039

1.70

10.16

1.4

1.3

4.66

5.28

umol/l

1.14

157

921

Sexual dysfunction

5.38

10.16

1.7

1.0

4.88

6.22

umol/l

0.51

266

1721

1.54

10.15

1.4

1.3

4.30

5.60

umol/l

6.98

241

1544

Cluster headache, wide

3.64

10.11

1.3

1.1

3.37

5.62

umol/l

3.31

Candidiasis, including avohilmo

202

1238

1.64

10.09

1.4

1.3

4.92

5.63

umol/l

1.97

179

1111

Hypertensive diseases (excluding secondary)

265

986

1.57

10.05

1.5

1.3

4.39

5.19

umol/l

2.71

239

858

Other diseases of urinary system

506

2060

1.38

10.04

1.4

1.3

5.02

5.27

umol/l

0.79

447

1848

Anomalies of dental arch relationship, including avohilmo

173

922

1.71

9.91

1.5

1.3

5.57

6.12

umol/l

1.00

147

833

Conjunctivitis (acute, non atopic), including avohilmo

497

2180

1.38

9.90

1.3

5.11

5.22

umol/l

0.26

438

1940

Emotionally unstable personality disorder

130

710

1.85

9.86

1.4

1.2

5.57

6.38

umol/l

1.57

116

646

Postpartum hemorraghe, parous women as controls

214

1113

1.62

9.84

1.3

5.97

5.49

umol/l

1.27

203

1003

Pain, not elsewhere classified

150

854

1.76

9.84

1.7

1.3

4.10

5.33

umol/l

4.18

138

760

Cluster headache, strict

3.66

9.84

1.3

1.1

3.27

5.75

umol/l

3.75

Implicit bacterial Sepsis, including avohilmo

135

613

1.84

9.84

1.3

1.2

3.46

4.07

umol/l

1.21

119

531

COPD/asthma/ILD related infections

513

1868

1.38

9.83

1.3

5.22

5.19

umol/l

0.03

453

1670

COPD/asthma related infections

513

1868

1.38

9.83

1.3

5.22

5.19

umol/l

0.03

453

1670

Primary ovarian failure

4.79

9.82

1.8

1.2

4.51

5.96

umol/l

1.23

Abnormal serum enzyme levels

372

2.16

9.80

1.2

1.3

3.54

4.17

umol/l

0.96

325

Disturbance of activity and attention

174

1011

1.70

9.77

1.3

6.19

6.38

umol/l

0.28

152

919

Disturbances of skin sensation

167

983

1.71

9.75

1.5

1.3

4.22

5.43

umol/l

4.46

146

874

Emotional disorders starting during childhood or adolecense, excluding more controls

333

2.25

9.73

1.4

6.91

6.77

umol/l

0.10

310

Chronic laryngitis and laryngotracheitis

238

2.49

9.73

1.2

3.15

4.21

umol/l

1.76

213

Disorders of psychological development

136

699

1.82

9.71

1.3

6.53

6.42

umol/l

0.11

126

634

Certain infectious and parasitic diseases, including avohilmo

349

1188

1.47

9.71

1.4

1.3

4.96

5.33

umol/l

0.87

311

1059

Implicit fungal Sepsis, including avohilmo

111

3.27

9.71

1.6

1.3

4.01

4.92

umol/l

0.94

Malignant neoplasm of thyroid gland, including Hilmo

138

3.00

9.57

1.2

1.4

3.54

4.84

umol/l

1.26

125

Other sleep disorders

259

2.41

9.50

1.3

1.2

4.70

5.44

umol/l

0.68

236

Dental pulpitis, including avohilmo

507

2391

1.36

9.42

1.3

5.36

5.44

umol/l

0.16

458

2127

Implicit bacterial Sepsis

119

544

1.88

9.41

1.3

1.2

3.39

4.00

umol/l

1.09

103

471

Caries of enamel

481

2300

1.37

9.40

1.3

5.40

5.02

umol/l

1.37

422

2048

Infections with a predominantly sexual mode of transmission, including avohilmo

320

2013

1.46

9.38

1.3

5.99

6.02

umol/l

0.05

288

1804

Social phobias

429

2.07

9.32

1.3

1.2

5.62

6.55

umol/l

1.24

391

Coxibs

138

393

1.85

9.31

1.3

1.2

6.14

5.77

umol/l

0.44

120

360

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

223

1236

1.57

9.28

1.5

1.3

3.60

4.22

umol/l

1.66

199

1083

Lumbar disc prolapse

262

1276

1.52

9.23

1.3

1.2

4.08

4.95

umol/l

3.38

227

1126

Complications of procedures, not elsewhere classified

363

2059

1.42

9.15

1.4

1.3

3.95

5.06

umol/l

7.33

326

1814

Disorders of refraction and accommodation

206

1298

1.59

9.08

1.3

1.4

5.33

5.52

umol/l

0.29

186

1160

Hypertension

321

1235

1.47

9.00

1.5

1.3

4.05

4.65

umol/l

2.12

287

1076

Functional dyspepsia

128

715

1.80

9.00

1.5

1.3

4.46

5.00

umol/l

0.96

109

645

Mycoses

139

797

1.75

8.95

1.4

1.3

4.34

5.11

umol/l

1.68

123

705

Continuous positive airway pressure

193

2.47

8.92

1.6

3.99

3.59

umol/l

0.37

169

Fever of other and unknown origin

265

1533

1.50

8.92

1.4

1.2

4.56

5.45

umol/l

3.39

240

1354

Abnormal findings on diagnostic imaging of other body structures

261

2.35

8.88

1.5

1.3

3.09

4.34

umol/l

2.08

233

Gastro-oesophageal reflux disease

279

1588

1.48

8.88

1.3

4.16

4.73

umol/l

1.71

238

1410

Polyneuropathies and other disorders of the peripheral nervous system

299

2.25

8.84

1.6

1.3

2.90

3.89

umol/l

1.89

257

Impotence

4.90

8.83

1.3

1.1

4.16

3.64

umol/l

0.23

Mouth breathing

160

956

1.68

8.81

1.4

4.48

4.39

umol/l

0.05

128

848

Hypertensive diseases

321

1241

1.46

8.81

1.5

1.3

4.05

4.66

umol/l

2.19

287

1082

Other symptoms and signs involving the digestive system and abdomen

398

2.07

8.78

1.4

4.60

4.62

umol/l

0.02

360

Autism spe

146

2.87

8.76

1.5

6.82

6.43

umol/l

0.22

133

Symptoms and signs involving the urinary system

298

1536

1.47

8.75

1.5

1.3

4.21

4.80

umol/l

1.77

265

1351

Symptoms and signs involving speech and voice

134

766

1.76

8.72

1.5

1.3

4.60

4.41

umol/l

0.10

117

684

Pain associated with micturition

276

2.30

8.71

1.4

1.3

4.85

4.79

umol/l

0.03

249

Shoulder lesions

260

1029

1.52

8.66

1.3

3.65

4.71

umol/l

4.28

222

901

Other symptoms and signs involving cognitive functions and awareness

146

757

1.71

8.58

1.5

1.2

3.72

4.17

umol/l

0.86

129

664

Disorders of ocular muscles, binocular movement, accommodation and refraction

295

2021

1.45

8.55

1.3

5.35

5.52

umol/l

0.31

262

1809

Eating disorder

130

743

1.77

8.53

1.2

5.96

6.58

umol/l

1.29

117

679

Impingement syndrome of shoulder

336

2.15

8.53

1.4

1.2

2.77

3.87

umol/l

1.97

292

Infections of the skin and subcutaneous tissue

303

2072

1.44

8.50

1.4

1.3

5.03

5.31

umol/l

0.64

278

1828

Asthma, unspecified (mode), excluding more controls

243

1146

1.52

8.47

1.4

1.2

3.78

5.18

umol/l

8.09

209

1031

Implicit Sepsis, including avohilmo

354

1793

1.41

8.47

1.4

1.3

3.87

5.08

umol/l

8.48

316

1578

Other abnormal uterine and vaginal bleeding

317

2.02

8.45

1.5

1.2

4.69

4.40

umol/l

0.31

280

Oxycodone

106

483

1.88

8.44

1.7

1.3

3.05

3.92

umol/l

1.92

428

Wide developmental disorders

231

2.42

8.39

1.5

6.75

5.79

umol/l

0.80

207

Condition for Implicit Sepsis (Organ dysfunction codes)

373

1851

1.40

8.37

1.4

1.3

3.95

5.10

umol/l

7.53

333

1630

Asthma, unspecified (mode)

243

1160

1.51

8.35

1.4

1.2

3.78

5.16

umol/l

7.92

209

1044

Other neurological diseases

248

1281

1.50

8.33

1.4

1.3

3.57

4.49

umol/l

4.04

217

1126

Superficial injury of abdomen, lower back and pelvis

100

531

1.89

8.32

1.6

1.2

4.83

5.78

umol/l

1.64

472

Pulmonary heart disease, diseases of pulmonary circulation

461

1.96

8.30

1.4

1.2

3.51

3.93

umol/l

0.59

405

Dipeptidyl peptidase 4 (DPP-4) inhibitors

127

562

1.77

8.29

1.2

1.3

3.40

3.44

umol/l

0.03

108

482

Visual disturbances and blindness

243

1626

1.50

8.28

1.3

4.99

5.05

umol/l

0.09

214

1443

Special screening examination for other diseases and disorders

295

2.21

8.26

1.7

1.2

4.46

6.01

umol/l

2.56

265

Osteoporosis

317

2.12

8.25

1.8

1.3

2.37

3.29

umol/l

2.19

286

Autism

151

2.77

8.24

1.5

6.82

6.37

umol/l

0.26

138

Hyperkinetic disorders

179

1097

1.61

8.20

1.3

6.12

6.32

umol/l

0.29

157

1000

Benign neoplasm: Stomach

118

2.98

8.18

1.7

1.3

3.68

3.71

umol/l

0.02

100

Malignant neoplasm of thyroid gland

129

2.89

8.17

1.2

1.4

3.82

4.81

umol/l

0.79

117

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

172

1075

1.61

8.08

1.3

5.12

6.03

umol/l

3.06

158

969

Cervicocranial syndrome

223

2.39

8.06

1.5

1.2

3.54

5.13

umol/l

2.24

198

Rash and other nonspecific skin eruption

217

2.41

8.06

1.9

1.3

4.20

4.96

umol/l

0.72

192

Asthma-related infections

296

2018

1.43

8.05

1.4

1.3

4.15

5.41

umol/l

7.25

265

1808

Asthma, hospital admission 2, infections

296

2018

1.43

8.05

1.4

1.3

4.15

5.41

umol/l

7.25

265

1808

Obsessive-compulsive disorder

372

2.07

8.04

1.2

6.48

6.58

umol/l

0.07

343

Visual disturbances

232

1552

1.50

7.99

1.3

5.05

5.09

umol/l

0.05

204

1380

Kela-code for severe mental illness

182

1156

1.58

7.95

1.2

1.3

5.53

5.50

umol/l

0.03

167

1019

Spondylopathies

260

1035

1.49

7.93

1.5

1.2

3.15

4.55

umol/l

9.54

220

907

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

194

609

1.60

7.93

1.4

1.2

5.68

6.13

umol/l

0.77

174

553

Pain in limb

431

2027

1.35

7.85

1.5

1.3

4.52

5.62

umol/l

7.63

391

1817

Diseases of the respiratory system

317

1108

1.44

7.83

1.4

1.2

5.05

5.36

umol/l

0.71

284

1000

Bipolar affective disorders

123

710

1.74

7.82

1.2

1.3

5.45

6.08

umol/l

1.10

113

641

Nontoxic goitre/thyroid nodule

100

542

1.85

7.82

1.3

3.37

3.90

umol/l

0.87

485

Cough

191

1147

1.56

7.79

1.4

1.3

4.44

5.28

umol/l

2.43

166

1033

Use of hypnotics and sedatives

446

1895

1.35

7.74

1.4

1.3

4.11

4.95

umol/l

5.20

393

1668

Urinary track infection

430

1592

1.36

7.60

1.4

1.3

5.09

5.55

umol/l

1.63

389

1447

Autoimmune diseases related-to ILD

404

2502

1.35

7.59

1.5

1.3

4.25

5.26

umol/l

6.34

359

2226

Diarrhoea and gastroenteritis of presumed infectious origin

362

2360

1.37

7.59

1.6

1.3

4.82

5.42

umol/l

2.33

316

2109

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

422

2118

1.35

7.54

1.4

1.3

4.26

5.26

umol/l

6.02

377

1878

Other and unspecified polyneuropathies, also in other diseases

230

2.31

7.53

1.7

1.2

2.87

4.01

umol/l

1.88

198

Pulmonary embolism

422

1.95

7.51

1.4

1.3

3.56

3.91

umol/l

0.44

371

Pulmonary heart disease

422

1.95

7.51

1.4

1.3

3.56

3.91

umol/l

0.43

371

Cardiovascular diseases

471

1885

1.33

7.38

1.4

1.3

5.31

6.14

umol/l

5.16

421

1696

Eating disorders

131

783

1.69

7.37

1.2

1.3

5.93

6.49

umol/l

1.10

118

713

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

371

2494

1.36

7.32

1.5

1.3

5.24

5.53

umol/l

0.80

331

2223

Mixed and other personality disorders

240

2.27

7.30

1.3

4.60

5.76

umol/l

1.69

216

Allergic rhinitis

232

1563

1.47

7.29

1.4

1.3

5.01

5.89

umol/l

2.87

204

1404

Rheumatism, unspecified

215

2.34

7.27

1.6

1.2

3.17

3.98

umol/l

0.89

194

Vitamin D deficiency

4.55

7.20

1.7

1.2

5.13

5.09

umol/l

0.01

Unspecified mental disorder

209

1400

1.50

7.20

1.3

5.51

5.54

umol/l

0.04

190

1229

Other systemic involvement of connective tissue (FG)

111

627

1.74

7.13

1.5

1.3

3.93

4.87

umol/l

2.13

569

Supervision of high-risk pregnancy

189

735

1.56

7.09

1.3

5.91

5.94

umol/l

0.03

179

662

Cholecystectomy

263

1564

1.43

7.03

1.4

1.3

4.19

4.42

umol/l

0.24

229

1382

Migraine with aura

190

1255

1.52

7.03

1.4

1.2

5.67

5.92

umol/l

0.44

175

1134

Substance abuse, excluding more controls

215

1210

1.49

7.03

1.2

1.3

4.79

5.45

umol/l

1.56

187

1078

Diabetes, insulin treatment (Kela reimbursement)

390

1720

1.35

7.01

1.4

1.3

4.01

4.65

umol/l

2.61

351

1505

Dizziness and giddiness

312

1749

1.39

6.98

1.4

1.3

4.44

4.92

umol/l

1.53

280

1546

Other and unspecified mood [affective] disorders

331

2.04

6.97

1.4

1.2

6.33

6.38

umol/l

0.04

307

Pain in thoracic spine

392

1.95

6.97

1.4

1.3

4.39

5.17

umol/l

1.02

346

Other maternal disorders predominantly related to pregnancy

376

1740

1.36

6.96

1.4

1.3

5.66

5.44

umol/l

0.51

349

1572

Cutaneous abscess, furuncle and carbuncle

136

834

1.64

6.94

1.4

1.3

5.01

5.39

umol/l

0.56

127

738

Symptoms and signs involving cognition, perception, emotional state and behaviour

439

2223

1.32

6.93

1.5

1.3

4.55

5.14

umol/l

2.62

397

1972

Certain disorders involving the immune mechanism

400

1.93

6.91

2.1

1.4

3.37

4.51

umol/l

2.14

351

Complications of surgical and medical care, not elsewhere classified

441

2233

1.32

6.89

1.3

3.98

5.18

umol/l

9.83

398

1974

Other disorders of eye and adnexa

458

1.87

6.85

1.4

4.64

5.15

umol/l

0.70

412

Cervical disc disorders

103

588

1.76

6.84

1.4

1.3

3.17

3.88

umol/l

1.66

505

Other eating disorders

396

1.95

6.84

1.1

1.2

5.81

6.58

umol/l

1.06

370

Candidiasis

410

1.91

6.78

1.4

1.3

4.69

5.35

umol/l

0.85

365

Voice disturbances

109

636

1.72

6.72

1.5

1.4

3.87

4.39

umol/l

0.88

572

Other inflammation of eyelid

323

2.02

6.64

1.5

1.3

3.72

4.89

umol/l

1.94

290

Cluster headache, wide,, including avohilmo

145

2.58

6.62

1.6

1.2

3.13

5.75

umol/l

5.33

130

Immunodeficiency with predominantly antibody defects

3.49

6.59

2.8

1.5

4.29

5.12

umol/l

0.40

Other systemic involvement of connective tissue

112

663

1.69

6.57

1.4

1.3

3.92

4.79

umol/l

1.93

600

Papillary adenocarcinoma of thyroid gland

2.97

6.54

1.2

1.5

3.47

4.96

umol/l

1.19

Deviated nasal septum

106

618

1.72

6.53

1.3

1.2

4.68

4.50

umol/l

0.17

536

Excessive attrition of teeth

330

2418

1.35

6.51

1.3

4.79

5.36

umol/l

2.28

296

2156

Other general symptoms and signs

187

2.35

6.49

1.3

1.4

4.30

5.24

umol/l

0.85

171

Disease of hard tissues of teeth, NOS

180

611

1.54

6.48

1.4

1.3

4.57

4.63

umol/l

0.07

158

523

Missing teeth due to accident, extraction or parodontitis

187

1115

1.50

6.48

1.5

1.3

3.32

4.08

umol/l

2.35

159

982

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

212

1459

1.46

6.46

1.3

5.34

5.95

umol/l

1.44

183

1318

Cluster headache, strict, including avohilmo

142

2.56

6.37

1.6

1.2

3.03

5.84

umol/l

5.85

127

Acetic acid derivatives and related substances

122

374

1.69

6.28

1.2

6.02

5.69

umol/l

0.35

103

342

Acute sinusitis

283

1868

1.38

6.27

1.3

5.11

5.36

umol/l

0.56

263

1676

ILD medications

567

2419

1.26

6.24

1.4

1.3

4.28

5.50

umol/l

12.27

493

2165

Deforming dorsopathies

130

811

1.61

6.23

1.4

1.3

4.32

5.20

umol/l

2.03

116

728

Systemic connective tissue disorders

136

859

1.59

6.20

1.4

3.82

4.67

umol/l

2.28

120

775

Polyarthrosis

218

2.15

6.19

1.2

2.23

3.32

umol/l

1.27

197

Glaucoma suspect

532

1.75

6.17

1.2

1.3

3.30

3.52

umol/l

0.30

478

Bacterial Sepsis

132

681

1.60

6.13

1.3

3.45

4.25

umol/l

1.78

114

590

Nerve, nerve root and plexus disorders

445

2063

1.30

6.10

1.4

1.3

4.22

5.08

umol/l

5.34

380

1839

Other and unspecified myopathies

2.84

6.09

1.1

1.2

3.14

4.33

umol/l

1.06

Failed induction of labour

435

1.84

6.05

1.1

1.3

6.16

6.27

umol/l

0.11

396

Endometriosis diagnosis and infertility diagnosis occurring together

427

1.84

6.05

1.2

1.3

6.03

5.19

umol/l

1.18

388

Hypertrophy of breast in women and men

109

657

1.67

6.02

1.4

1.3

4.85

5.03

umol/l

0.19

100

584

Injuries to the abdomen, lower back, lumbar spine and pelvis

177

1176

1.49

5.99

1.5

1.3

4.35

5.35

umol/l

3.34

154

1053

Gonarthrosis

182

684

1.50

5.97

1.5

1.3

2.87

4.03

umol/l

4.29

149

607

Emotional disorders and disorders of social functioning with onset specific to childhood

442

1.82

5.96

1.4

6.73

6.68

umol/l

0.04

404

Diseases of oesophagus, stomach and duodenum

473

2181

1.28

5.93

1.4

1.3

4.16

5.18

umol/l

7.36

406

1950

Ocular pain

276

2.04

5.91

1.3

5.00

5.25

umol/l

0.20

251

Chronic rhinitis, nasopharyngitis and pharyngitis

156

1028

1.52

5.91

1.4

1.3

4.76

5.20

umol/l

0.64

133

911

Suicide or other Intentional self-harm

142

919

1.55

5.86

1.3

4.98

5.86

umol/l

1.79

117

825

Rotator cuff syndrome

171

783

1.51

5.84

1.3

1.2

3.14

4.12

umol/l

3.32

148

682

Cholelithiasis

315

1596

1.35

5.84

1.3

4.06

4.63

umol/l

1.00

280

1412

Immunodeficiencies

119

2.63

5.81

2.4

1.5

3.99

4.83

umol/l

0.60

107

Osteopathies and chondropathies

220

1420

1.42

5.77

1.6

1.3

3.84

4.83

umol/l

3.97

190

1260

Falls/tendency to fall

559

2232

1.26

5.77

1.4

1.3

5.38

5.27

umol/l

0.26

485

2004

Paralytic ileus and intestinal obstruction

354

1.90

5.77

1.4

1.2

2.92

3.65

umol/l

1.37

312

Pain in throat and chest

400

1817

1.30

5.76

1.3

4.31

5.50

umol/l

8.42

358

1636

Asthma (diagnoses ohter than nonallergic)

425

2676

1.28

5.70

1.4

1.3

4.13

5.38

umol/l

9.97

369

2397

Trochanteric bursitis

246

2.08

5.70

1.6

1.2

2.97

3.86

umol/l

1.52

219

Other congenital malformations

407

1.83

5.68

1.6

1.5

4.72

5.39

umol/l

0.82

363

Transport accidents

251

1514

1.38

5.61

1.4

1.3

5.15

5.42

umol/l

0.57

226

1365

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

308

2217

1.33

5.56

1.4

1.3

4.79

5.42

umol/l

2.62

270

1985

Insulin medication

207

1206

1.43

5.55

1.4

4.30

4.83

umol/l

1.15

186

1051

Smoking dependency

171

2.29

5.52

1.1

1.3

4.73

4.87

umol/l

0.08

152

Constipation

358

1851

1.31

5.51

1.5

1.3

3.86

4.78

umol/l

5.35

321

1630

Cholelithiasis, broad definition with cholecystitis

324

1622

1.33

5.50

1.3

4.02

4.64

umol/l

1.16

289

1434

485

1.74

5.48

1.4

1.3

5.04

5.72

umol/l

0.88

431

Substance use, excluding alcohol

101

613

1.65

5.48

1.3

5.13

5.62

umol/l

0.54

545

Other shoulder lesions

217

2.13

5.46

1.4

1.2

5.15

5.26

umol/l

0.05

191

Hypoplasia of dental enamel , including avohilmo

274

2.00

5.46

2.0

1.5

4.19

5.65

umol/l

2.24

248

Symptoms and signs concerning food and fluid intake

264

2.01

5.43

1.3

1.4

4.08

4.94

umol/l

1.00

237

DVT of lower extremities and pulmonary embolism

107

657

1.62

5.42

1.4

1.3

3.74

3.94

umol/l

0.24

571

External causes of morbidity and mortality

355

1351

1.32

5.39

1.4

1.3

5.41

5.46

umol/l

0.07

321

1217

Other and unspecified nerve root and plexus disorders, also in other diseases

465

1.75

5.39

1.5

1.3

4.06

4.65

umol/l

0.82

412

Mental and behavioural disorders due to tobacco

173

2.27

5.38

1.1

1.3

4.73

4.81

umol/l

0.04

154

Dermatophytosis, including avohilmo

287

2103

1.34

5.38

1.3

5.00

5.20

umol/l

0.38

258

1859

Persons encountering health services in circumstances related to reproduction

269

1326

1.36

5.34

1.5

1.3

5.34

5.25

umol/l

0.13

241

1163

Allergic conjunctivitis

322

2361

1.31

5.29

1.4

1.3

4.76

5.38

umol/l

2.67

281

2123

Anorexia (incl.atypical)

359

1.86

5.29

1.2

6.11

6.40

umol/l

0.30

337

Subjective visual disturbances

118

751

1.58

5.28

1.2

1.3

5.07

5.04

umol/l

0.03

103

668

Congenital malformations, deformations and chromosomal abnormalities

337

2450

1.31

5.28

1.5

1.3

5.12

5.62

umol/l

1.65

298

2188

Other symptoms and signs involving the circulatory and respiratory systems

125

2.49

5.28

2.2

1.4

3.87

5.28

umol/l

1.13

114

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

329

1573

1.32

5.28

1.3

6.05

6.18

umol/l

0.26

293

1435

Infections, IBD-co-morbidities

193

2.01

5.26

1.6

1.3

4.67

5.50

umol/l

0.76

165

Brachial plexus disorders

275

1.98

5.25

1.7

1.2

3.34

5.24

umol/l

5.58

246

Other arthrosis

145

639

1.52

5.24

1.6

1.3

3.06

4.02

umol/l

2.80

120

567

Postpartum haemorrhage

214

1263

1.40

5.24

1.3

5.97

5.75

umol/l

0.43

203

1137

ILD medications: prednisolone, methylprednisolone, prednisone

520

2318

1.25

5.23

1.4

1.3

4.20

5.45

umol/l

6.67

455

2074

Myopia

606

1.64

5.23

1.3

5.30

5.85

umol/l

0.85

537

Schizophrenia, schizotypal and delusional disorders

149

1001

1.49

5.21

1.2

1.3

5.41

5.57

umol/l

0.17

135

880

Exposure to unspecified factor

490

2666

1.25

5.21

1.4

1.3

5.15

5.21

umol/l

0.12

429

2384

Pruritus

339

1.87

5.20

1.6

1.3

5.10

5.38

umol/l

0.22

303

Congenital malformations of anterior segment of eye

7.56

5.18

1.1

4.02

5.79

umol/l

—

Thyrotoxicosis, other and/or unspecified

501

1.70

5.17

1.5

1.2

4.41

5.03

umol/l

0.91

447

Asthma, hospital admissions , main diagnosis only

396

2702

1.28

5.15

1.4

1.3

4.36

5.35

umol/l

6.07

345

2424

Diseases of male genital organs

108

330

1.65

5.15

1.3

1.4

4.43

4.48

umol/l

0.04

272

Chronic gastritis

347

1.85

5.15

1.5

1.3

2.88

3.69

umol/l

1.83

314

Arthropathies

511

2068

1.25

5.14

1.3

5.54

5.71

umol/l

0.44

450

1869

Other obstetric conditions, not elsewhere classified

328

1579

1.32

5.09

1.3

6.00

6.17

umol/l

0.37

292

1440

Schizophrenia or delusion

148

1000

1.48

5.05

1.2

1.3

5.45

5.58

umol/l

0.14

134

879

Pregnancy examination and test

164

692

1.48

5.03

1.3

6.25

6.28

umol/l

0.02

148

623

Epilepsy

124

805

1.54

5.03

1.5

1.3

4.93

4.97

umol/l

0.04

110

721

Tinnitus

490

1.70

5.02

1.4

1.2

4.87

4.40

umol/l

0.45

433

Dermatitis

263

1921

1.34

5.01

1.3

4.42

5.05

umol/l

2.16

235

1708

COPD-related respiratory insufficiency

2.70

5.00

1.8

1.3

1.96

3.00

umol/l

1.44

Exposure to other specified factors

398

2695

1.27

4.97

1.3

5.23

5.26

umol/l

0.06

356

2403

Benign neoplasm of colon, rectum, anus and anal canal

152

872

1.47

4.94

1.1

1.3

3.12

3.51

umol/l

0.75

136

759

Viral and other specified intestinal infections, including avohilmo

218

1527

1.38

4.93

1.4

1.3

5.37

6.29

umol/l

2.96

195

1379

Other disorders of skin and subcutaneous tissue

269

1701

1.34

4.93

1.4

1.3

4.40

4.65

umol/l

0.51

238

1500

Syncope and collapse

169

978

1.44

4.92

1.3

1.2

4.26

5.30

umol/l

3.34

151

870

Suppurative and unspecified otitis media

269

1790

1.33

4.90

1.4

1.3

5.93

6.05

umol/l

0.20

245

1602

Calculus of kidney and ureter

524

1.66

4.89

1.1

1.3

3.96

4.52

umol/l

0.78

453

Diverticular disease of intestine

171

734

1.45

4.88

1.3

1.2

3.00

3.46

umol/l

1.07

153

637

Poisoning by drugs, medicaments and biological substances

147

1000

1.48

4.88

1.2

1.3

4.96

5.96

umol/l

2.59

129

897

Urolithiasis

548

1.65

4.86

1.1

1.3

3.95

4.49

umol/l

0.77

476

Erosion of teeth , including avohilmo

169

1182

1.43

4.85

1.4

1.3

4.82

5.77

umol/l

2.75

155

1056

Poisoning by medicine

135

904

1.50

4.85

1.2

1.3

4.95

5.97

umol/l

2.48

117

814

Allergic urticaria

312

1.87

4.84

1.7

1.3

5.69

5.41

umol/l

0.20

283

Carbimazole or st.post thyroidectomy, condition for graves disease

619

1.61

4.82

1.4

1.3

4.37

4.74

umol/l

0.42

555

Nonsuppurative otitis media, including avohilmo

242

1551

1.35

4.82

1.5

1.3

5.90

6.22

umol/l

0.62

217

1403

Molar incisor enamel hypoplasia

299

1.88

4.81

1.9

1.5

4.14

5.59

umol/l

2.28

272

Postmenopausal bleeding

182

1.87

4.80

1.7

1.2

2.58

2.39

umol/l

0.25

167

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

225

1636

1.36

4.80

1.5

1.3

5.19

5.80

umol/l

1.67

197

1476

Pure hypercholesterolaemia

190

852

1.42

4.79

1.3

3.24

3.81

umol/l

1.43

169

730

Postpartum care and examination

153

653

1.48

4.76

1.3

6.44

6.36

umol/l

0.10

141

587

Diplopia

257

1.95

4.76

1.4

3.90

4.79

umol/l

1.12

228

Diaphragmatic hernia

559

1.63

4.75

1.2

1.3

2.98

3.70

umol/l

1.55

496

Benign neoplasm: Colon

123

759

1.52

4.75

1.2

1.3

3.04

3.41

umol/l

0.62

109

660

Diseases of external ear

147

1006

1.46

4.73

1.3

4.80

4.89

umol/l

0.12

130

898

Type 1 diabetes

118

771

1.53

4.72

1.6

1.4

4.46

5.32

umol/l

2.07

102

668

Insulin, intermediate and long-acting

181

1241

1.41

4.71

1.3

4.11

4.65

umol/l

1.34

161

1091

Inflammatory diseases of prostate (prostatitis)

102

2.56

4.70

1.2

1.1

3.78

3.81

umol/l

0.01

Gingivitis and periodontal diseases

406

1655

1.27

4.68

1.4

1.3

4.75

4.96

umol/l

0.49

372

1447

Concussion

253

1467

1.34

4.67

1.4

1.3

4.84

5.63

umol/l

2.85

223

1338

Fenamates

254

1.80

4.67

1.4

1.2

4.24

5.23

umol/l

1.46

232

Injury of muscle and tendon at shoulder and upper arm level

532

1.64

4.64

1.3

1.2

4.21

3.61

umol/l

0.78

460

Gonarthrosis [arthrosis of knee](FG)

199

818

1.40

4.63

1.4

1.3

2.80

3.90

umol/l

4.55

164

717

Fissure and fistula of anal and rectal regions

540

1.63

4.63

1.3

1.2

5.00

4.83

umol/l

0.15

478

Primary gonarthrosis, bilateral

110

592

1.56

4.63

1.2

1.3

2.09

3.09

umol/l

3.52

100

517

Dermatophytosis

232

1.99

4.63

1.4

1.3

3.76

4.58

umol/l

0.86

203

Cardiovascular diseases (excluding rheumatic etc)

425

1938

1.26

4.62

1.4

1.3

4.88

5.90

umol/l

6.68

379

1736

Fibroblastic disorders

318

1.83

4.55

1.6

1.2

3.30

3.87

umol/l

0.69

277

Accidents

402

1593

1.27

4.55

1.4

1.3

5.46

5.26

umol/l

0.45

359

1438

Pollen allergy

162

1124

1.43

4.53

1.4

1.3

5.09

6.01

umol/l

2.40

144

1016

Other enthesopathies

104

669

1.56

4.50

1.5

1.2

3.86

4.82

umol/l

2.00

587

Oxicams

237

1.75

4.49

1.4

1.2

4.75

4.74

umol/l

0.01

213

Unspecified haematuria

105

548

1.56

4.48

1.3

3.38

3.99

umol/l

1.04

473

Adverse effects, not elsewhere classified

123

823

1.50

4.47

1.4

1.3

4.24

5.66

umol/l

4.78

108

739

Disorders of eyelid, lacrimal system and orbit

360

2081

1.27

4.44

1.4

1.3

4.18

4.98

umol/l

3.68

318

1852

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

431

2706

1.24

4.43

1.4

1.3

4.85

5.26

umol/l

1.57

385

2412

Localized swelling, mass and lump of skin and subcutaneous tissue

125

841

1.49

4.41

1.3

4.15

4.79

umol/l

1.32

111

747

Migraine with aura and triptan purchases

137

940

1.47

4.41

1.4

1.3

5.40

6.09

umol/l

1.45

126

850

Benign paroxysmal vertigo

563

1.60

4.40

1.3

3.87

4.11

umol/l

0.31

505

Extrapyramidal and movement disorders

111

729

1.53

4.39

1.4

1.3

4.29

4.09

umol/l

0.25

101

647

Urticaria

179

1289

1.39

4.39

1.5

1.3

5.30

5.46

umol/l

0.23

161

1145

Oral corticosteroids

473

2251

1.23

4.39

1.4

1.3

3.96

5.33

umol/l

7.17

416

2002

Insulin, combination of fast acting with intermediate-acting or long-acting

207

1381

1.36

4.38

1.4

1.3

4.30

4.72

umol/l

0.87

186

1214

Diseases of salivary glands

142

984

1.45

4.33

1.2

1.3

4.00

5.11

umol/l

3.45

126

877

Carpal tunnel syndrome

207

1324

1.36

4.27

1.3

3.79

4.43

umol/l

1.81

174

1179

Other and unspecified effects of external causes

166

1187

1.40

4.26

1.4

1.3

4.78

5.77

umol/l

2.72

143

1063

Other chronic obstructive pulmonary disease, including avohilmo

109

586

1.53

4.25

1.3

2.48

3.41

umol/l

3.05

503

Single spontaneous delivery

147

1105

0.70

4.25

1.3

6.03

5.84

umol/l

0.25

139

995

Enthesopathies of lower limb, excluding foot

553

1.60

4.24

1.6

1.3

4.10

4.78

umol/l

1.02

489

Melanocytic naevi

160

1139

1.41

4.22

1.6

1.3

5.05

5.37

umol/l

0.53

143

1020

Other female pelvic inflammatory diseases

454

1.66

4.21

1.4

1.3

3.74

4.99

umol/l

2.25

409

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

399

1868

1.25

4.20

1.4

1.3

4.54

5.19

umol/l

2.76

352

1670

399

1868

1.25

4.20

1.4

1.3

4.54

5.19

umol/l

2.76

352

1670

Emotional disorders starting during childhood or adolescence

459

1.66

4.20

1.4

6.91

6.55

umol/l

0.31

421

Thyrotoxicosis

106

699

1.52

4.15

1.5

1.3

4.38

4.70

umol/l

0.44

626

Other and unspecified dermatitis

223

1678

1.33

4.15

1.3

4.52

5.07

umol/l

1.53

200

1492

Glaucoma

128

742

1.47

4.12

1.3

3.17

3.54

umol/l

0.64

110

658

Intestinal stricture

465

1.64

4.09

1.4

1.3

3.16

3.85

umol/l

1.05

410

Convulsions, not elsewhere classified

120

805

1.48

4.07

1.5

1.3

4.46

5.85

umol/l

4.16

103

717

Other diseases of lip and oral mucosa

173

1256

1.38

4.07

1.3

5.37

4.86

umol/l

0.39

152

1113

Oter anti-inflammatory and antirheumatic agents, non-steroids

132

1.96

4.06

1.4

1.2

3.35

3.57

umol/l

0.15

118

COPD (mode)

249

1.79

4.04

1.3

1.2

2.12

3.39

umol/l

3.20

220

Other and unspecified nonorganic psychotic disorders

106

704

1.51

4.03

1.2

1.3

5.89

5.95

umol/l

0.05

623

Disorders of gallbladder, biliary tract and pancreas

367

1825

1.25

4.01

1.4

1.3

4.01

4.77

umol/l

1.90

326

1612

Problems related to lifestyle

303

1.79

3.99

1.3

1.2

5.18

5.97

umol/l

0.84

263

Haemorrhoids and perianal venous thrombosis

100

653

1.52

3.97

1.1

1.2

4.80

4.73

umol/l

0.06

576

Other immunodeficiencies

4.54

3.96

2.3

1.6

3.39

4.76

umol/l

0.65

Urticaria and erythema

202

1510

1.34

3.96

1.4

1.3

5.22

5.37

umol/l

0.22

182

1340

Disorders of lipoprotein metabolism and other lipidaemias

219

996

1.34

3.95

1.3

3.38

3.98

umol/l

1.74

194

856

Viral infections of the central nervous system, including avohilmo

184

2.02

3.93

1.3

4.46

5.40

umol/l

0.86

159

Other extrapyramidal and movement disorders in other diseases

486

1.61

3.93

1.4

1.3

4.59

4.33

umol/l

0.24

432

Other external causes of accidental injury

395

1593

1.24

3.92

1.4

1.3

5.53

5.26

umol/l

0.65

352

1438

Anogenital herpesviral [herpes simplex] infection, including avohilmo

102

678

1.51

3.90

1.5

1.3

4.93

6.29

umol/l

4.09

614

Asthma and allergy

613

1.54

3.90

1.7

1.3

4.73

5.97

umol/l

2.30

564

Transient ischemic attack

107

567

1.50

3.90

1.3

1.2

2.43

3.31

umol/l

3.31

499

Otitis externa, unspecified

350

1.72

3.89

1.4

4.84

5.30

umol/l

0.51

318

Other or unspecified ileus, impaction or obstruction

219

1.92

3.89

1.4

1.2

3.15

3.73

umol/l

0.60

193

Heart failure, not strict

189

934

1.36

3.88

1.5

1.3

3.11

3.58

umol/l

0.41

159

824

Heart failure and antihypertensive medication

161

1.90

3.88

1.5

1.4

3.12

4.22

umol/l

1.30

141

Abnormal findings on diagnostic imaging of lung

101

633

1.51

3.88

1.5

1.3

2.84

3.43

umol/l

1.09

548

Early lumbar disc prolapse, operated

336

1.73

3.86

1.3

1.2

5.08

5.67

umol/l

0.65

293

Spondylolisthesis/Spondylolysis

299

1.78

3.85

1.4

1.3

3.78

4.18

umol/l

0.34

263

Benign neoplasm: Colon, unspecified

299

1.78

3.85

1.2

1.3

2.50

3.20

umol/l

0.98

262

All influenza

104

695

1.50

3.85

1.5

1.3

4.77

5.13

umol/l

0.45

610

Congenital malformations and deformations of the musculoskeletal system

479

1.61

3.85

1.9

1.4

4.76

5.71

umol/l

1.56

433

COPD related to multimorbidity

352

1.66

3.83

1.4

1.2

2.18

3.19

umol/l

2.81

305

Conjunctivitis (acute, non atopic)

157

1130

1.39

3.82

1.1

1.3

4.52

5.45

umol/l

3.14

141

1008

Otitis externa

108

729

1.49

3.82

1.4

5.16

5.29

umol/l

0.17

652

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

318

1967

1.26

3.74

1.3

5.46

5.25

umol/l

0.40

285

1776

Abnormalities of gait and mobility

181

2.00

3.72

1.4

3.29

4.03

umol/l

0.61

159

Asthma and allergy, excluding more controls

614

1.52

3.68

1.7

1.3

4.78

5.94

umol/l

2.08

565

Open bite

350

1.70

3.66

1.5

1.4

5.07

5.89

umol/l

0.90

324

Leisure time condition

543

1.55

3.65

1.3

5.22

5.66

umol/l

0.44

487

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

103

696

1.49

3.65

1.3

5.18

6.01

umol/l

1.27

622

Type of accident

135

960

1.41

3.64

1.3

4.95

5.41

umol/l

0.70

128

857

Cervicobrachial syndrome

520

1.56

3.63

1.6

1.3

3.10

4.71

umol/l

4.98

456

Early lumbar disc prolapse operation

373

1.67

3.63

1.4

1.2

5.10

5.61

umol/l

0.53

329

Acute suppurative otitis media

208

1475

1.32

3.62

1.3

5.99

6.25

umol/l

0.45

186

1324

Female genital prolapse

274

1.61

3.60

1.4

1.2

3.60

3.49

umol/l

0.10

242

Clear cell adenocarcinoma of kidney

3.73

3.59

1.0

1.4

2.05

2.96

umol/l

1.08

Other diseases of hard tissues of teeth

164

615

1.38

3.57

1.4

1.3

4.69

4.61

umol/l

0.08

147

527

Allergic asthma (mode)

136

949

1.40

3.55

1.5

1.2

4.67

5.81

umol/l

2.97

120

867

Thyrotoxicosis with diffuse goitre

360

1.67

3.55

1.7

1.2

4.70

5.09

umol/l

0.41

320

Injury, poisoning and certain other consequences of external causes

283

1113

1.28

3.54

1.4

1.3

5.51

5.58

umol/l

0.11

252

1004

Hypercalcemia

3.06

3.53

2.2

1.3

5.36

3.79

umol/l

0.48

COPD

435

1.55

3.52

1.4

1.2

2.49

3.51

umol/l

2.59

375

Other diseases of anus and rectum

594

1.51

3.51

1.3

1.2

4.19

4.38

umol/l

0.18

527

Noninfective enteritis and colitis

209

1600

1.31

3.49

1.4

4.19

5.37

umol/l

5.19

186

1414

Disorders of tooth development and eruption

412

1.56

3.48

1.3

4.93

5.47

umol/l

0.69

354

Childhood asthma (age<16), excluding more controls

129

714

1.42

3.47

1.2

5.86

6.47

umol/l

0.95

110

659

Infections with a predominantly sexual mode of transmission

204

1558

1.31

3.45

1.3

5.62

5.88

umol/l

0.53

181

1390

Childhood asthma (age<16)

129

715

1.42

3.45

1.2

5.86

6.46

umol/l

0.94

110

660

Chronic lower respiratory diseases

569

2537

1.18

3.44

1.4

1.3

4.53

5.42

umol/l

3.98

495

2275

Diseases of pulp and periapical tissues, including avohilmo

498

2155

1.20

3.44

1.3

5.30

5.39

umol/l

0.18

447

1926

Allergic asthma (mode), excluding more controls

135

947

1.39

3.43

1.5

1.2

4.70

5.81

umol/l

2.83

119

865

Factors influencing health status and contact with health services

261

1.58

3.43

1.3

1.2

5.31

5.66

umol/l

0.31

230

Pleural plaque

2.99

3.41

1.2

1.3

1.61

2.05

umol/l

—

Diseases of the digestive system

151

1099

1.37

3.40

1.5

1.3

3.83

4.82

umol/l

3.19

131

977

Viral and other specified intestinal infections

161

1165

1.35

3.40

1.4

1.3

5.37

6.45

umol/l

3.05

143

1046

Effects of foreign body entering through natural orifice

100

683

1.47

3.38

1.6

1.3

5.04

5.36

umol/l

0.37

607

Injuries to the neck

124

882

1.41

3.38

1.6

1.2

4.92

5.77

umol/l

1.77

106

791

Covid-19 confirmed case

143

1040

1.38

3.38

1.4

1.3

4.54

5.16

umol/l

1.24

126

929

Angina pectoris

107

486

1.46

3.34

1.3

1.95

3.20

umol/l

6.22

418

Dislocation, sprain and strain of joints and ligaments at neck level

654

1.47

3.31

1.6

1.2

4.67

6.04

umol/l

3.43

592

Presence of other functional implants

134

657

1.40

3.31

1.5

1.3

3.02

3.60

umol/l

1.19

120

580

Superficial injury of ankle and foot

573

1.51

3.31

1.4

1.3

5.81

6.08

umol/l

0.30

513

Other chronic obstructive pulmonary disease

413

1.55

3.30

1.4

1.2

2.49

3.53

umol/l

2.47

355

Disorders of synovium and tendon

219

1440

1.29

3.30

1.4

1.2

4.49

5.37

umol/l

2.86

194

1277

Hypermobility syndrome

248

1.79

3.29

1.6

1.2

4.66

6.06

umol/l

1.66

228

ILD medications: azathioprine

446

1.58

3.28

1.4

1.3

3.17

5.34

umol/l

7.69

394

Scoliosis

384

1.62

3.28

1.7

1.3

5.20

6.03

umol/l

0.91

350

Heartburn

255

1.77

3.28

1.4

1.2

4.16

5.29

umol/l

1.52

230

Benign neoplasm: Rectum, anus and anal canal

248

1.78

3.26

1.1

1.3

3.25

3.56

umol/l

0.27

216

Persons with potential health hazards related to communicable diseases

264

2089

1.26

3.22

1.4

1.3

5.17

5.88

umol/l

2.81

244

1863

Supplementary factors related to causes of morbidity and mortality classified elsewhere

143

1051

1.36

3.22

1.3

4.85

5.48

umol/l

1.18

133

935

Sequelae of external causes of morbidity and mortality

552

1.51

3.22

1.4

1.3

4.15

4.74

umol/l

0.68

487

Hyperplasia of prostate

173

1.73

3.21

1.1

2.92

3.42

umol/l

0.60

143

Deep bite

519

1.50

3.21

1.5

1.4

4.98

5.89

umol/l

1.22

469

Gonarthrosis,primary

204

943

1.30

3.18

1.3

2.57

3.41

umol/l

3.34

171

820

Chronic sinusitis

167

1257

1.33

3.18

1.4

1.2

4.40

5.09

umol/l

1.73

151

1114

Salpingitis and oophoritis

387

1.61

3.18

1.5

1.4

3.50

4.07

umol/l

0.74

352

Delivery

158

1112

0.75

3.17

1.3

5.90

5.85

umol/l

0.06

149

1001

Acute bronchitis

163

1201

1.33

3.17

1.5

1.3

4.78

5.07

umol/l

0.43

147

1070

Early onset COPD, excluding more controls

243

1.77

3.16

1.4

1.2

3.17

3.76

umol/l

0.57

214

Dental operations

172

660

1.34

3.15

1.4

1.3

4.51

4.58

umol/l

0.08

151

571

Codes for special purposes

247

1947

1.26

3.12

1.4

1.3

4.95

5.48

umol/l

1.40

214

1735

Diseases of arteries, arterioles and capillaries (FINNGEN)

227

1.67

3.12

1.2

3.02

4.42

umol/l

2.17

191

Other disorders of the musculoskeletal system and connective tissue

237

1.78

3.12

1.8

1.3

2.68

4.35

umol/l

2.81

207

Allergic contact dermatitis

437

1.56

3.10

1.4

1.3

4.84

5.60

umol/l

1.07

390

Other congenital malformations, including avohilmo

598

1.48

3.09

1.5

1.4

4.80

5.60

umol/l

1.32

533

Inflammatory diseases of the central nervous system

180

1.90

3.09

1.7

1.3

4.61

5.02

umol/l

0.27

158

Diabetic maculopathy, excluding more controls

173

1.91

3.08

1.4

1.2

4.83

5.23

umol/l

0.26

152

Other bacterial intestinal infections, including avohilmo

550

1.49

3.07

1.5

1.3

5.07

5.00

umol/l

0.05

494

Vulvovaginal ulceration/inflammation in other diseases

345

1.63

3.06

1.7

1.2

5.02

6.03

umol/l

1.17

314

Colonic or urogenital fistula

624

1.46

3.05

1.3

4.97

4.76

umol/l

0.21

554

Postpartum hemorraghe, all women as controls

214

1638

1.28

3.05

1.3

5.97

5.81

umol/l

0.28

203

1470

Provisional assignment of new diseases of uncertain etiology

246

1945

1.26

3.05

1.4

1.3

4.96

5.48

umol/l

1.37

213

1733

Arthrosis

214

909

1.29

3.04

1.5

1.3

3.60

4.68

umol/l

3.96

176

804

Other noninfective gastroenteritis and colitis

110

782

1.41

3.03

1.4

4.49

5.30

umol/l

1.48

691

Fracture of rib(s), sternum and thoracic spine

495

1.52

3.03

1.6

1.3

4.37

4.29

umol/l

0.07

433

Azathioprine

456

1.54

3.01

1.4

1.3

3.17

5.42

umol/l

8.15

403

Insulin, fast-acting

133

977

1.36

3.01

1.4

1.3

4.35

4.99

umol/l

1.18

117

858

Type 1 diabetes, wide definition, subgroup 1

675

1.44

3.01

1.5

1.4

4.41

5.32

umol/l

2.38

583

Diseases of liver

692

1.43

3.01

1.3

3.81

4.24

umol/l

0.60

610

Erysipelas

138

877

1.36

3.00

1.2

1.3

3.66

4.10

umol/l

0.73

124

760

Other and unspecified immunodeficiencies with predominantly antibody defects

3.91

2.99

3.5

1.5

3.66

5.62

umol/l

—

Emergency coronary revascularization (for ACS)

206

964

1.29

2.99

1.3

1.4

2.60

3.53

umol/l

4.58

179

837

Inflammatory bowel disease treatment related agents

523

2477

1.17

2.95

1.3

4.20

5.46

umol/l

6.90

461

2212

Perineal laceration during delivery

179

1111

1.31

2.94

1.2

1.3

6.45

6.20

umol/l

0.42

164

1011

Haemorrhage from respiratory passages

504

1.48

2.94

1.3

5.06

4.54

umol/l

0.19

447

Type 1 diabetes, wide definition

695

1.43

2.93

1.5

1.4

4.37

5.28

umol/l

2.42

603

Pedal cyclist injured in transport accident

104

738

1.41

2.93

1.5

1.3

4.95

5.56

umol/l

0.95

652

Stomatitis and related lesions

680

1.43

2.92

1.2

1.3

4.73

5.40

umol/l

1.04

602

Other disorders of the genitourinary system

184

1.85

2.91

1.6

1.4

2.86

3.54

umol/l

0.79

165

Injuries to the knee and lower leg

550

2552

1.17

2.90

1.3

5.33

5.23

umol/l

0.18

482

2284

Mental and behavioural disorders due to psychoactive substance use

228

1660

1.26

2.89

1.2

1.3

4.76

5.44

umol/l

1.77

198

1464

Benign neoplasm: Rectum

221

1.77

2.88

1.1

1.3

3.23

3.57

umol/l

0.28

190

Other septicaemia

103

689

1.41

2.87

1.4

1.3

3.28

4.26

umol/l

2.59

603

Asthma-related pneumonia

117

848

1.38

2.85

1.5

1.3

3.48

4.76

umol/l

3.48

103

753

Viral infections of the central nervous system

164

1.90

2.85

1.3

1.4

4.45

5.36

umol/l

0.74

143

Acute laryngitis and tracheitis

617

1.44

2.82

1.3

5.36

6.15

umol/l

1.11

551

Disorders of vestibular function (Vertigo)

137

996

1.34

2.82

1.4

1.3

4.08

4.19

umol/l

0.15

123

873

Sarcoidosis

208

1.78

2.81

2.3

1.3

2.99

4.45

umol/l

1.95

181

Short stature starting before birth

2.88

2.80

1.3

1.8

3.77

3.81

umol/l

0.01

Asthma-related pneumonia or sepsis

117

851

1.37

2.80

1.5

1.3

3.48

4.76

umol/l

3.50

103

756

Asthma, hospital admissions 3, pneumonia

117

851

1.37

2.80

1.5

1.3

3.48

4.76

umol/l

3.50

103

756

Haemorrhage in early pregnancy

164

1223

1.31

2.79

1.3

5.04

5.29

umol/l

0.43

156

1096

Maternal care for other known or suspected fetal problems

230

1148

1.26

2.78

1.2

1.3

6.18

6.13

umol/l

0.08

205

1041

Thyroiditis, unspecified

3.96

2.78

1.2

1.0

5.57

5.82

umol/l

—

Injury of muscle and tendon at hip and thigh level

209

1.78

2.78

1.4

1.3

4.52

4.94

umol/l

0.25

184

Any death

719

0.67

2.77

1.2

1.3

3.51

3.14

umol/l

0.35

626

Septicaemia

114

755

1.38

2.77

1.4

1.3

3.31

4.25

umol/l

2.55

103

658

Fall on same level

550

2527

1.16

2.76

1.3

5.12

5.30

umol/l

0.52

492

2258

Adhesive capsulitis of shoulder

239

1.72

2.76

1.3

1.2

3.41

3.82

umol/l

0.38

211

Gonarthrosis, primary, with knee surgery

106

591

1.40

2.74

1.2

1.3

2.10

2.90

umol/l

1.79

515

Other disorders of breast

484

1.49

2.72

1.6

1.3

4.71

5.24

umol/l

0.56

439

Percutaneous Coronary Intervention

197

937

1.28

2.71

1.3

1.4

2.61

3.57

umol/l

4.58

173

811

Crossbite

401

1.53

2.70

1.7

1.5

5.01

5.69

umol/l

0.81

364

Complications of internal orthopaedic prosthetic devices, implants and grafts

271

1.66

2.70

1.1

1.3

2.39

3.45

umol/l

1.09

237

Renal failure

572

1.42

2.69

1.4

1.3

2.91

3.61

umol/l

1.82

496

Explicit Sepsis

138

946

1.33

2.68

1.4

1.3

3.54

4.69

umol/l

3.86

127

830

Premature rupture of membranes

190

1060

1.28

2.67

1.2

1.3

6.49

6.01

umol/l

1.01

170

959

Insulin, fast-acting or short human

134

1007

1.33

2.66

1.4

1.3

4.32

4.97

umol/l

1.22

118

887

Assault

454

1.50

2.66

1.2

5.71

6.08

umol/l

0.26

397

Malignant neoplasm of breast

665

0.68

2.65

1.4

2.71

3.75

umol/l

2.41

598

239

1.71

2.65

2.4

1.4

4.75

5.37

umol/l

0.56

217

Substance abuse

215

1596

1.25

2.65

1.2

1.3

4.79

5.43

umol/l

1.54

187

1412

Assault by bodily force

250

1.69

2.65

1.0

1.2

6.37

6.13

umol/l

0.11

222

Inflammatory disease of uterus

686

1.41

2.64

1.3

5.07

5.84

umol/l

1.21

618

Malignant neoplasm of breast, including Hilmo

683

0.68

2.64

1.4

2.82

3.79

umol/l

2.15

614

Malignant neoplasm of breast, HER2-negative, including Hilmo

683

0.68

2.64

1.4

2.82

3.79

umol/l

2.15

614

Artrosis, including avohilmo

276

1231

1.23

2.64

1.5

1.3

3.73

4.86

umol/l

6.43

235

1079

Chronic kidney disease

375

1.54

2.63

1.3

1.4

2.85

3.64

umol/l

1.60

331

Benign neoplasm of other and unspecified sites

2.67

2.62

2.1

1.3

3.42

4.95

umol/l

0.81

Torsion of ovary, ovarian pedicle and fallopian tube

2.95

2.62

1.2

1.1

5.53

5.01

umol/l

0.17

Diseases of oral cavity, salivary glands and jaws

157

615

1.32

2.61

1.5

1.3

4.65

4.61

umol/l

0.04

141

527

Nonsuppurative otitis media

189

1293

1.27

2.61

1.4

1.3

6.32

6.51

umol/l

0.26

169

1171

Intracranial injury

252

1914

1.23

2.60

1.4

1.3

4.98

5.49

umol/l

1.38

224

1704

Vasomotor rhinitis (mode)

141

1.92

2.60

1.6

1.4

4.55

5.11

umol/l

0.25

125

Dermatographic urticaria

244

1.69

2.60

1.2

1.3

4.21

5.48

umol/l

1.60

221

Fracture of foot, except ankle

122

910

1.34

2.58

1.5

1.3

4.74

5.56

umol/l

1.57

106

805

Other viral diseases, not elsewhere classified, including avohilmo

161

1241

1.29

2.58

1.4

4.97

5.67

umol/l

1.66

148

1105

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

105

765

1.38

2.57

1.7

1.2

4.31

5.20

umol/l

1.89

668

Persons encountering health services for specific procedures and health care

494

2512

1.16

2.57

1.4

1.3

4.13

5.45

umol/l

12.65

426

2255

Mental and behavioural disorders due to sedatives or hypnotics

156

1.87

2.56

1.3

1.2

5.46

5.45

umol/l

0.00

138

209

1.75

2.56

1.7

1.5

4.96

5.36

umol/l

0.28

187

Other acute lower respiratory infections

226

1739

1.24

2.55

1.5

1.3

4.82

5.45

umol/l

1.64

206

1543

Melanocytic naevi of scalp and neck

2.44

2.55

1.2

1.1

5.98

6.32

umol/l

0.11

Retention of urine

388

1.48

2.54

1.2

3.89

4.25

umol/l

0.35

340

Open wound of ankle and foot

284

1.63

2.54

1.1

1.3

4.55

5.78

umol/l

1.54

252

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

588

1.43

2.53

1.9

1.4

4.82

5.72

umol/l

1.56

532

Contraceptive management

186

1024

1.27

2.52

1.3

5.59

5.57

umol/l

0.02

163

902

Intracranial trauma

273

1515

1.22

2.51

1.4

1.3

4.81

5.63

umol/l

3.17

240

1384

Coronary revascularization (ANGIO or CABG)

195

937

1.26

2.48

1.3

1.4

2.65

3.57

umol/l

4.27

170

811

Benign neoplasm: Pancreas

3.48

2.48

2.0

1.1

2.48

3.83

umol/l

—

Injuries to the wrist and hand

467

2668

1.16

2.48

1.3

5.11

5.22

umol/l

0.27

420

2377

Malignant neoplasm of breast, HER2-negative

663

0.69

2.48

1.4

2.69

3.76

umol/l

2.53

596

COPD, early/later onset

454

1.44

2.47

1.4

1.2

2.49

3.36

umol/l

1.90

391

Other bacterial intestinal infections

333

1.56

2.47

1.7

1.3

5.01

4.80

umol/l

0.13

299

Other septicaemia, including avohilmo

103

707

1.37

2.46

1.4

1.3

3.28

4.24

umol/l

2.52

616

Embedded and impacted teeth

242

1605

1.23

2.44

1.3

6.56

6.43

umol/l

0.22

221

1459

Recurrent aphthous stomatitis , including avohilmo

455

1.48

2.44

1.2

1.4

4.43

5.49

umol/l

1.49

412

Other inflammation of eyelid, including avohilmo

242

1985

1.22

2.41

1.3

5.09

5.56

umol/l

1.28

220

1775

COPD, hospital admissions

452

1.44

2.39

1.4

1.2

2.51

3.35

umol/l

1.79

389

Spirochaetal infections, other/unspecified, including avohilmo

111

827

1.34

2.39

1.3

4.18

4.43

umol/l

0.43

735

Fall on and from stairs and steps

101

742

1.36

2.38

1.4

1.3

4.57

5.21

umol/l

1.07

660

Other viral diseases, including avohilmo

235

1906

1.22

2.38

1.4

1.3

5.16

5.83

umol/l

2.16

214

1697

L04AD Calcineurin inhibitors

274

1.61

2.37

1.3

1.5

2.97

4.79

umol/l

4.43

246

Diseases of inner ear

152

1133

1.28

2.36

1.4

1.3

4.11

4.17

umol/l

0.08

136

994

Cellulitis

583

1.41

2.35

1.4

1.3

4.76

5.12

umol/l

0.46

509

Spontaneous rupture of synovium and tendon

104

2.02

2.35

1.7

1.2

4.40

4.17

umol/l

0.10

Sub-endpoint used in defining T1D endpoints

119

884

1.33

2.34

1.6

1.4

4.42

5.28

umol/l

2.15

103

779

Restless leg syndrome

314

1.56

2.34

1.4

1.3

5.26

4.65

umol/l

0.51

277

Melanocytic naevi of trunk

346

1.54

2.34

2.0

1.3

5.11

5.36

umol/l

0.18

311

Conduction disorders

392

1.45

2.33

1.3

1.4

4.30

4.34

umol/l

0.03

348

Viral infections characterized by skin and mucous membrane lesions

175

1390

1.26

2.33

1.5

1.3

4.60

5.09

umol/l

1.24

159

1236

Appendectomy

283

2249

1.20

2.33

1.2

1.3

4.92

5.22

umol/l

0.70

251

1997

Pedal cyclist injured in other and unspecified transport accidents

307

1.57

2.32

1.4

1.3

5.06

5.71

umol/l

0.54

272

Benign neoplasm of ovary

355

1.52

2.31

1.4

1.3

3.80

4.01

umol/l

0.19

324

Contact with and exposure to communicable diseases

230

1881

1.22

2.28

1.4

1.3

5.43

6.00

umol/l

1.80

214

1687

Lyme disease, including avohilmo

109

817

1.34

2.27

1.3

4.21

4.40

umol/l

0.28

727

Lyme disease

109

817

1.34

2.27

1.3

4.21

4.40

umol/l

0.28

727

Explicit Sepsis, including avohilmo

139

975

1.29

2.27

1.4

1.3

3.54

4.71

umol/l

4.01

127

858

Disorder of external ear, unspecified

2.57

2.27

1.1

1.3

4.72

umol/l

0.00

Other diseases of blood and blood-forming organs, wide

446

1.46

2.27

1.4

1.3

4.09

4.50

umol/l

0.33

392

Benign neoplasm of eye and adnexa

178

1.75

2.26

1.5

1.3

3.92

4.38

umol/l

0.29

156

Ischemic heart diseases

212

1021

1.24

2.25

1.3

1.4

2.69

3.74

umol/l

5.67

184

891

Other diseases of pleura

539

1.39

2.24

1.5

1.2

2.68

3.70

umol/l

2.62

464

Other superficial mycoses, including avohilmo

432

1.46

2.22

1.3

5.86

5.98

umol/l

0.08

386

Open wound of wrist and hand

195

1526

1.24

2.21

1.3

5.08

5.62

umol/l

1.49

176

1342

Crohn disease

400

1.48

2.20

1.5

1.3

3.65

5.72

umol/l

6.52

358

Other spirochaetal diseases, including avohilmo

112

848

1.32

2.19

1.3

4.15

4.47

umol/l

0.56

751

False labour

245

1255

1.21

2.19

1.4

1.3

5.98

5.94

umol/l

0.05

229

1137

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

152

1199

1.27

2.19

1.4

1.3

4.95

5.67

umol/l

1.66

139

1062

Metatarsalgia

210

1.67

2.19

1.3

1.2

4.08

4.90

umol/l

0.67

189

Superficial injury of head

667

1.37

2.19

1.2

1.3

4.42

5.20

umol/l

1.18

593

Other spirochaetal diseases

110

831

1.33

2.19

1.3

4.19

4.43

umol/l

0.39

740

Benign lipomatous neoplasm

575

1.39

2.18

1.4

1.3

3.88

4.14

umol/l

0.29

511

Undetermined asthma, excluding more controls

304

1.55

2.17

1.4

1.3

3.78

5.12

umol/l

1.79

273

Autoimmune diseases excluding thyroid diseases

440

2066

1.15

2.16

1.5

1.2

4.38

5.52

umol/l

7.34

390

1845

Sacrococcygeal disorders, not elsewhere classified

2.31

2.15

2.5

1.2

3.96

5.24

umol/l

0.80

Postmenopausal atrophic vaginitis

197

1.52

2.14

1.6

1.2

2.74

2.71

umol/l

0.02

180

Other medical care

139

910

1.28

2.14

1.3

3.91

4.54

umol/l

1.36

121

807

Acute pharyngitis

109

818

1.32

2.13

1.3

5.53

6.25

umol/l

1.32

742

Volume depletion

137

1.83

2.13

1.9

1.5

4.59

4.32

umol/l

0.13

116

Caries of dentine, including avohilmo

287

1229

1.19

2.12

1.3

4.74

4.93

umol/l

0.31

256

1081

Endometriosis ASRM stages 3,4

110

836

1.32

2.12

1.3

4.27

5.12

umol/l

1.77

100

755

Examination and encounter for administrative purposes

2.01

2.10

1.5

1.1

3.60

4.43

umol/l

0.42

Other sexually transmitted chlamydial diseases

405

1.47

2.10

1.1

1.2

7.18

6.63

umol/l

0.55

363

Undetermined asthma

307

1.53

2.09

1.4

1.3

3.78

5.13

umol/l

1.81

276

Heterophoria

332

1.51

2.08

1.4

5.09

5.56

umol/l

0.39

299

Giant cell arteritis

2.91

2.07

1.0

1.4

1.90

2.48

umol/l

—

GI-bleeding

522

1.40

2.06

1.3

3.33

4.38

umol/l

2.59

461

Other viral diseases, not elsewhere classified

725

1.34

2.06

1.6

1.4

4.45

5.47

umol/l

2.31

643

Scleritis and episcleritis

139

1.81

2.05

1.3

1.4

3.50

5.09

umol/l

1.06

121

Abnormal findings in secretions and smears from cervix uteri vagina vulva

297

1854

1.18

2.04

1.3

5.59

5.35

umol/l

0.48

268

1683

Fracture of lower leg, including ankle

199

1602

1.22

2.04

1.3

5.23

4.82

umol/l

0.33

168

1417

Overexertion and strenuous or repetitive movements

207

1.65

2.04

1.4

1.3

4.65

5.49

umol/l

0.62

179

Viral pneumonia (known virus, not influenza)

2.41

2.03

1.9

1.4

4.48

5.17

umol/l

0.19

Other and unspecified erythematous conditions

2.41

2.03

1.2

5.67

5.02

umol/l

0.17

Other diseases of the digestive system

533

1.39

2.02

1.3

3.42

4.40

umol/l

1.86

470

Other benign neoplasms of skin

109

834

1.31

2.01

1.4

1.3

4.55

4.45

umol/l

0.09

742

Malignant neoplasm of mesothelium and soft tissue

2.64

2.00

1.0

1.2

3.51

4.23

umol/l

—

Ptosis of eyelid

140

1.79

2.00

1.2

1.3

3.16

4.03

umol/l

0.73

124

Other disorders of urethra and urinary system

310

1838

1.17

2.00

1.5

1.2

4.32

5.34

umol/l

5.58

270

1652

AV-block

170

1.66

2.00

1.0

1.3

3.69

4.01

umol/l

0.15

149

Diabetic retinopathy, excluding more controls

564

0.72

1.99

1.3

4.01

5.07

umol/l

2.07

517

Propionic acid derivatives

122

471

1.30

1.98

1.5

1.3

6.14

5.50

umol/l

0.97

107

430

Cardiac murmurs and other cardiac sounds

430

1.43

1.97

1.7

1.4

4.26

5.99

umol/l

2.95

393

Lateral epicondylitis

248

1.58

1.97

1.7

1.2

3.38

4.28

umol/l

1.02

214

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

256

1870

1.19

1.96

1.4

1.3

5.31

5.27

umol/l

0.05

237

1691

Statin medication

278

1321

1.19

1.95

1.4

1.3

4.48

5.14

umol/l

2.34

245

1167

Other viral diseases

168

1357

1.24

1.95

1.4

4.96

5.78

umol/l

2.44

151

1211

Diseases of arteries, arterioles and capillaries

140

811

1.27

1.94

1.2

1.3

3.36

3.85

umol/l

1.03

127

709

COPD, hospital admission 2, with asthma infections

296

1.48

1.94

1.6

1.3

2.83

3.47

umol/l

0.74

256

Delivery, wide proxy

149

988

0.80

1.93

1.2

1.3

6.26

6.06

umol/l

0.28

139

888

Other and unspecified tonsillitis

219

1515

1.20

1.92

1.3

5.75

6.07

umol/l

0.60

193

1360

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

258

1.55

1.91

1.5

1.3

4.27

4.58

umol/l

0.23

227

Bacterial pneumonia (organism specified)

129

919

1.27

1.91

1.4

1.3

4.52

4.89

umol/l

0.47

112

814

Anogenital herpesviral [herpes simplex] infection

315

1.50

1.90

1.7

1.3

3.69

6.06

umol/l

6.95

287

Meningitis

1.93

1.90

1.5

1.3

4.66

5.43

umol/l

0.47

Postpartum haemorrhage due to retained placenta

704

1.33

1.89

1.2

1.3

6.27

5.74

umol/l

0.78

643

Complications following infusion, transfusion and therapeutic injection

3.21

1.88

1.1

1.6

5.92

5.15

umol/l

—

Peroneal tendinitis

3.20

1.88

1.6

1.1

3.91

6.73

umol/l

—

Diabetic retinopathy

682

0.74

1.88

1.3

3.90

4.68

umol/l

1.46

623

Ectopic pregnancy

645

1.34

1.86

1.3

1.4

5.62

5.04

umol/l

0.71

577

Other other unspecified disorders of the circulatory system

2.40

1.85

2.1

1.4

3.09

3.43

umol/l

0.13

Other enthesopathy of foot (+metatarsalgia)

237

1.57

1.84

1.3

1.2

4.32

5.10

umol/l

0.64

211

Other infectious diseases

115

1.83

1.82

1.2

3.66

4.86

umol/l

0.71

104

Venous thromboembolism

128

977

1.26

1.82

1.4

1.3

3.76

4.09

umol/l

0.50

120

846

Other and unspecified rosacea

183

1.64

1.81

1.3

4.59

4.80

umol/l

0.14

164

Other retinal disorders

156

958

1.24

1.81

1.3

3.63

4.21

umol/l

1.34

134

848

Other symptoms and signs involving general sensations and perceptions

2.06

1.80

1.9

1.1

5.17

5.52

umol/l

0.11

Atopic dermatitis, strict definition with reimbursement

207

1662

1.20

1.79

1.4

1.3

4.98

6.02

umol/l

3.43

188

1492

Atrial fibrillation and flutter

310

1.40

1.79

1.1

1.3

3.16

4.35

umol/l

1.97

268

Other and unspecified vasculitis limited to skin

2.77

1.79

1.4

1.1

2.91

4.69

umol/l

—

Endometriosis ASRM stages 1,2

101

780

1.30

1.79

1.2

1.3

4.39

5.48

umol/l

2.13

707

Other sexually transmitted chlamydial diseases, including avohilmo

101

781

1.30

1.78

1.3

1.2

7.16

6.91

umol/l

0.29

702

Other disorders of amniotic fluid and membranes

116

881

1.28

1.78

1.2

1.3

6.24

5.94

umol/l

0.43

106

797

Chronic pancreatitis

146

1.72

1.77

1.6

1.3

2.81

4.35

umol/l

1.86

120

Other infective otitis externa

124

1.78

1.76

1.3

1.4

5.96

5.13

umol/l

0.57

110

Sequelae with surgical and medical care as external cause

387

1.42

1.75

1.2

1.3

4.02

4.49

umol/l

0.35

346

Other disorders of patella

531

1.36

1.75

1.4

1.3

4.26

5.25

umol/l

1.94

479

Erysipelas, including avohilmo

202

1247

1.20

1.74

1.2

1.3

3.80

4.47

umol/l

1.70

181

1082

Impacted teeth

196

1403

1.20

1.73

1.3

6.67

6.63

umol/l

0.06

179

1277

Disorders of breast

246

1842

1.18

1.72

1.4

1.3

4.58

5.14

umol/l

1.60

222

1667

Bacterial pneumoniae

121

843

1.26

1.70

1.4

1.3

4.63

4.97

umol/l

0.39

104

742

Atherosclerosis, excluding cerebral and coronary sclerosis

304

1.42

1.70

1.1

1.3

2.12

2.72

umol/l

1.20

256

Personal history of other diseases and conditions

714

1.30

1.68

1.4

1.3

5.72

5.88

umol/l

0.15

648

Calcific aortic valvular stenosis, diagnosis (helper)

233

1.53

1.68

1.0

1.3

2.20

2.81

umol/l

0.83

201

Operations 2 for CAVS

233

1.53

1.68

1.0

1.3

2.20

2.81

umol/l

0.83

201

Presbyopia

141

1.71

1.68

1.5

1.4

2.33

4.17

umol/l

4.39

118

5-aminosalicylic acid

700

1.30

1.68

1.3

4.09

5.62

umol/l

3.93

620

Other erythematous conditions

2.19

1.67

1.2

5.68

4.94

umol/l

0.19

Congenital malformations of genital organs

473

1.37

1.67

1.7

1.4

5.27

5.73

umol/l

0.56

424

Hernia of abdominal wall

124

992

1.25

1.67

1.4

1.3

4.38

umol/l

0.00

113

871

Atrial fibrillation and flutter with reimbursement

181

1.50

1.67

1.1

1.2

2.53

3.74

umol/l

1.20

151

Other skin changes

383

1.41

1.66

1.2

1.3

4.48

4.76

umol/l

0.21

338

Inguinal or femoral hernia, bilateral

1.86

1.65

1.3

1.2

3.77

4.08

umol/l

0.11

Calcific aortic valvular stenosis, including rheumatic fever

234

1.52

1.65

1.0

1.3

2.20

2.80

umol/l

0.82

202

Coagulation defects, purpura and other haemorrhagic conditions

546

1.34

1.64

1.4

1.3

5.43

5.01

umol/l

0.35

495

Benign neoplasm of thyroid gland

2.26

1.64

1.5

1.3

4.96

5.18

umol/l

0.06

Otitis media, unspecified

639

1.30

1.63

1.7

1.3

5.60

6.46

umol/l

1.31

581

Calcific aortic valvular stenosis

235

1.52

1.63

1.0

1.3

2.20

2.80

umol/l

0.82

203

Calcific aortic valvular stenosis, operated

235

1.52

1.63

1.0

1.3

2.20

2.80

umol/l

0.82

203

Complications of labour and delivery

340

1648

1.15

1.63

1.3

5.45

umol/l

0.01

308

1485

Benign neoplasm of middle ear and respiratory system

105

1.81

1.62

1.2

1.3

2.62

4.58

umol/l

1.92

Ganglion

660

1.31

1.62

1.2

5.19

5.50

umol/l

0.31

583

Pacemaker

373

1.40

1.62

1.1

1.3

2.28

3.48

umol/l

2.51

321

Combinations of oral blood glucose lowering drugs

327

1.44

1.61

1.1

1.2

2.84

3.57

umol/l

1.16

272

Dental caries, including avohilmo

236

1025

1.18

1.60

1.3

4.93

4.81

umol/l

0.16

210

898

Vasculitis limited to skin, not elsewhere classified

2.51

1.60

1.4

1.1

2.91

4.61

umol/l

—

Bacterial pneumonia, not elsewhere classified

112

781

1.26

1.59

1.4

1.3

4.58

4.94

umol/l

0.40

686

Spinal instabilities

2.70

1.58

2.3

1.2

3.10

4.64

umol/l

—

Outcome of delivery

655

0.77

1.58

1.3

5.51

6.03

umol/l

0.91

588

Other and unspecified urticaria

778

1.28

1.57

1.4

1.3

5.48

5.44

umol/l

0.04

694

Other abnormal immunological findings in serum

2.05

1.54

2.2

1.3

4.11

4.48

umol/l

0.19

Drug-induced neutropenia

107

1.78

1.54

1.2

1.4

2.36

4.36

umol/l

2.64

Optic atrophy

2.44

1.54

1.3

1.5

4.40

4.18

umol/l

—

Diabetic maculopathy

465

0.67

1.53

1.4

1.3

4.83

5.42

umol/l

0.44

432

Psoriasis vulgaris

390

1.39

1.53

1.2

1.3

4.80

4.91

umol/l

0.06

343

Major coronary heart disease event

194

975

1.19

1.53

1.3

1.4

2.65

3.56

umol/l

4.24

171

847

Bacterial infection, other or unspecified

136

936

1.23

1.52

1.2

1.3

3.69

4.32

umol/l

1.19

114

820

Other specified/unspecified deforming dorsopathies

3.35

1.52

1.0

1.1

1.90

5.00

umol/l

—

Malignant neoplasm of tonsil and base of tongue

3.35

1.52

1.0

1.1

2.00

3.72

umol/l

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

3.35

1.52

1.0

1.1

2.00

3.72

umol/l

—

Hypertrophy of breast

632

1.30

1.52

1.5

1.3

4.80

5.01

umol/l

0.21

566

Acute pancreatitis

307

1.44

1.51

1.7

1.2

3.19

4.52

umol/l

2.20

263

Residual foreign body in soft tissue

108

1.77

1.50

1.4

1.1

3.81

5.51

umol/l

1.32

Nutritional anaemias

155

1226

1.21

1.50

1.3

3.72

4.73

umol/l

3.54

139

1086

Desensitization to allergens

275

1.46

1.49

1.3

1.4

5.26

6.14

umol/l

0.96

250

Chronic periodontitis, complicated

138

1106

1.22

1.47

1.2

1.3

3.38

3.94

umol/l

1.20

114

971

Ulcer of lower limb, not elsewhere classified

155

1.61

1.46

1.2

1.4

2.50

3.92

umol/l

2.22

130

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

389

2331

1.12

1.46

1.4

1.3

4.10

5.05

umol/l

5.37

349

2061

Anti-inflammatory and antirheumatic products, non-steroids

117

471

1.25

1.46

1.5

1.3

6.18

5.50

umol/l

1.00

101

430

Ischaemic heart disease, wide definition

154

784

1.21

1.45

1.3

2.10

3.47

umol/l

7.75

125

683

Maternal care related to the fetus and amniotic cavity and possible delivery problems

282

1439

1.15

1.45

1.3

5.67

5.75

umol/l

0.13

259

1306

Bacterial intestinal infections, IBD co-morbidities

352

1.39

1.44

1.6

1.4

4.85

4.78

umol/l

0.04

313

Keratitis

131

1075

1.22

1.44

1.3

4.99

5.06

umol/l

0.07

115

956

Spondyloarthritis

429

1.35

1.43

1.4

1.2

3.99

5.59

umol/l

2.29

380

Disorders of sclera, cornea, iris and ciliary body

199

1698

1.17

1.43

1.4

1.3

4.61

5.05

umol/l

0.85

171

1496

Family history of malignant neoplasm

387

1.37

1.43

2.0

1.3

4.27

5.24

umol/l

1.21

352

Pregnancy hypertension

234

1806

1.16

1.42

1.4

1.3

5.40

5.36

umol/l

0.06

216

1630

Single delivery by forceps and vacuum extractor

111

819

0.81

1.42

1.2

1.3

5.94

6.17

umol/l

0.29

101

743

Fracture of lumbar spine and pelvis

352

1.39

1.42

1.4

1.3

3.18

4.37

umol/l

2.34

314

Eustachian salpingitis and obstruction

253

1.47

1.42

1.3

5.22

5.30

umol/l

0.04

224

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

293

1.42

1.2

1.3

3.08

3.25

umol/l

0.13

252

Burns and corrosions

430

1.35

1.42

1.3

1.4

5.54

5.51

umol/l

0.01

382

Autoimmune diseases excluding thyroid diseases, strict definition

403

1957

1.12

1.39

1.5

1.2

4.48

5.58

umol/l

6.46

354

1750

Inguinal hernia, bilateral

1.77

1.38

1.4

1.2

3.57

4.12

umol/l

0.20

Cyst of kidney

1.94

1.38

1.7

1.2

2.13

3.51

umol/l

1.30

Abrasion of teeth

121

993

1.22

1.35

1.4

1.3

4.33

4.73

umol/l

0.54

107

878

Vitreous haemorrhage

143

1.61

1.35

1.2

1.3

3.53

4.51

umol/l

0.64

125

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

228

1952

1.15

1.35

1.3

5.76

5.84

umol/l

0.12

208

1741

Haemangioma, any site

199

1.51

1.34

1.4

1.3

4.18

4.83

umol/l

0.44

177

Other arrhythmias

237

1535

1.15

1.34

1.3

3.72

5.01

umol/l

6.28

206

1361

Malignant neoplasm of colon, including Hilmo

182

1.53

1.34

1.2

1.4

2.36

3.25

umol/l

1.02

158

Cysts of oral region, not elsewhere classified

120

1.67

1.34

1.3

5.00

5.34

umol/l

0.13

105

Redundant prepuce, phimosis and paraphimosis

236

1.46

1.34

1.3

1.4

3.91

5.20

umol/l

1.30

193

Laparoscopic right hemicolectomy

2.13

1.33

1.1

1.4

1.76

3.11

umol/l

—

Viral warts, including avohilmo

113

923

1.23

1.33

1.3

5.66

5.69

umol/l

0.03

102

824

Status epilepticus

2.04

1.33

1.3

1.1

3.35

4.78

umol/l

0.67

Maternal care for cervical incompetence

136

1.63

1.33

1.2

6.74

5.72

umol/l

0.41

128

Spondylopathies (FG)

393

1.35

1.32

1.5

1.3

4.14

5.66

umol/l

1.91

350

Herpesviral [herpes simplex] infections, including avohilmo

132

1098

1.20

1.30

1.2

1.3

5.10

5.49

umol/l

0.60

115

975

Pneumonia due to other infectious organisms, not elsewhere classified

2.10

1.30

1.1

1.3

3.18

4.51

umol/l

—

Chronic periodontitis, including avohilmo

338

1917

1.12

1.30

1.2

1.3

4.21

4.86

umol/l

2.50

291

1697

Peripheral artery disease

357

1.33

1.30

1.1

1.2

2.30

3.12

umol/l

1.72

303

Optic atrophy, wide definition

2.37

1.29

1.3

1.6

4.40

4.28

umol/l

—

Early onset COPD

309

1.39

1.29

1.4

1.3

3.17

3.91

umol/l

0.77

267

Atopic dermatitis, strict definition

206

1742

1.16

1.28

1.4

1.3

4.99

6.00

umol/l

3.24

186

1566

Focal epilepsy, strict definition

499

1.30

1.28

1.5

1.4

4.86

4.78

umol/l

0.07

441

Foreign body in ear

1.95

1.28

1.3

4.35

5.76

umol/l

0.66

Inflammatory bowel disease

128

1064

1.20

1.28

1.4

1.3

3.93

5.46

umol/l

5.77

113

943

Haemorrhage, not elsewhere classified

2.09

1.27

1.0

1.2

3.38

3.78

umol/l

—

Injuries to the thorax

125

1036

1.21

1.27

1.4

1.3

4.59

4.74

umol/l

0.18

111

913

Other infectious diseases, including avohilmo

162

1.55

1.25

1.2

1.3

4.13

4.92

umol/l

0.43

144

Lichen ruber planus, wide definition including periferal and oral lichen planus

388

1.34

1.25

1.4

1.3

4.02

3.83

umol/l

0.12

339

Carcinoma in situ of skin

1.82

1.25

1.1

1.3

1.87

2.95

umol/l

—

Dislocation, sprain and strain of joints and ligaments of knee

274

2187

1.13

1.25

1.4

1.3

5.22

5.34

umol/l

0.22

241

1963

Polyarthropathies

195

1451

0.86

1.25

1.2

1.3

3.88

5.38

umol/l

7.54

166

1297

Obstructive hydrocephalus

2.41

1.24

1.2

1.1

2.43

5.08

umol/l

—

COPD, hospital admissions 1, only main diagnosis

318

1.35

1.24

1.6

1.3

2.52

3.40

umol/l

1.26

276

Chromosomal abnormalities, not elsewhere classified

123

1.64

1.24

2.3

1.5

3.87

4.73

umol/l

0.59

110

Other obstetric trauma

290

0.62

1.23

1.2

1.3

6.44

5.99

umol/l

0.21

263

Benign neoplasm: Skin of scalp and neck

2.01

1.23

1.4

1.2

5.71

4.94

umol/l

—

Cerebral aneurysm, nonruptured

131

1.61

1.23

1.3

1.4

2.75

3.80

umol/l

1.20

111

Periodontitis

338

1924

1.12

1.22

1.2

1.3

4.21

4.87

umol/l

2.55

292

1702

Congenital malformations of the circulatory system

549

1.28

1.21

1.3

1.5

4.12

5.24

umol/l

1.83

495

Insulin, fast-acting (human)

408

1.33

1.21

1.4

1.3

4.26

5.57

umol/l

2.93

358

Foreign body on external eye

271

1.40

1.21

1.2

1.3

5.98

5.56

umol/l

0.23

234

Iron deficiency anaemia

135

1113

1.19

1.20

1.2

1.4

3.67

4.81

umol/l

3.75

122

993

Other infections specific to the perinatal period

2.15

1.19

1.1

1.4

3.73

5.40

umol/l

—

Heart failure,strict

461

1.26

1.19

1.3

1.2

2.53

3.24

umol/l

1.48

399

Adjustment and management of implanted device

205

1.46

1.19

1.4

1.3

2.91

3.63

umol/l

0.59

180

Influenza and pneumonia

470

2639

1.10

1.19

1.4

1.3

4.63

5.34

umol/l

3.66

419

2352

Preterm labour and delivery

114

945

1.21

1.19

1.4

1.3

4.94

4.92

umol/l

0.02

106

839

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

418

1.32

1.18

1.2

1.4

4.04

4.86

umol/l

1.07

378

Crowding of teeth, including avohilmo

625

1.24

1.18

1.7

1.4

6.04

6.62

umol/l

0.63

573

Papulosquamous disorders

112

928

1.21

1.18

1.3

1.4

4.33

4.62

umol/l

0.31

821

Coronary atherosclerosis

110

570

1.22

1.17

1.4

1.3

2.16

3.52

umol/l

4.66

492

Bacterial infection, other or unspecified, including avohilmo

160

1119

1.17

1.3

3.94

4.61

umol/l

1.41

135

984

Acute pancreatitis (for exclusion)

324

1.36

1.17

1.7

1.3

3.19

4.48

umol/l

2.11

278

Other fall from one level to another

105

866

1.21

1.16

1.5

1.3

5.49

5.82

umol/l

0.39

770

Nystagmus and other irregular eye movements

2.07

1.15

1.3

1.6

3.90

5.02

umol/l

—

Cardiac arrhythmias

253

1430

1.13

1.15

1.3

4.03

5.57

umol/l

9.18

216

1265

Superficial injury of hip and thigh

325

1.36

1.15

1.3

5.29

5.25

umol/l

0.02

293

STROKE

128

722

1.19

1.14

1.3

2.83

4.08

umol/l

5.18

109

628

Glomerular diseases

352

1.34

1.13

1.4

1.3

4.17

4.61

umol/l

0.37

311

Chondrocostal junction syndrome [Tietze]

1.76

1.13

1.6

1.3

3.94

6.04

umol/l

1.21

Diagnoses used for exclusion with ILD

387

1.32

1.12

2.2

1.3

3.26

4.01

umol/l

1.05

336

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

467

1.29

1.12

1.2

1.4

4.73

5.67

umol/l

1.45

417

Colorectal cancer, including Hilmo

280

1.37

1.12

1.1

1.3

2.30

3.14

umol/l

1.51

242

Calculus of lower urinary tract

2.00

1.12

1.0

1.1

4.14

3.83

umol/l

—

Coeliac disease

405

1.31

1.12

1.7

1.4

3.97

5.18

umol/l

2.05

365

Other gastritis (incl. Duodenitis)

345

1.33

1.10

1.6

1.2

3.13

4.16

umol/l

1.19

312

Organic, including symptomatic, mental disorders

464

1.24

1.10

1.5

1.3

3.06

3.15

umol/l

0.10

406

Disorders of lens

141

741

1.18

1.10

1.4

1.3

2.96

3.62

umol/l

1.53

128

643

Other abnormal products of conception

230

1329

1.14

1.09

1.2

1.3

5.72

5.70

umol/l

0.03

217

1208

Open wound of abdomen, lower back and pelvis

1.74

1.09

1.0

1.2

5.56

5.97

umol/l

—

Problems related to social environment

1.83

1.09

2.3

1.1

5.53

6.33

umol/l

0.33

Other predominantly sexually transmitted diseases, not elsewhere classified

100

828

1.21

1.08

1.4

1.3

6.32

5.88

umol/l

0.63

740

Burns and corrosions of external body surface, specified by site

329

1.34

1.08

1.3

1.4

5.56

5.71

umol/l

0.08

291

Focal epilepsy, mode (most common among epilepsy diagnosis)

478

1.28

1.07

1.5

1.4

4.89

4.90

umol/l

0.01

423

Other bacterial diseases

322

1918

1.11

1.07

1.3

3.89

4.83

umol/l

4.46

279

1687

Superficial injury of lower leg

119

1003

1.19

1.07

1.4

1.3

6.25

5.48

umol/l

0.47

106

899

Diseases of appendix

288

2307

1.12

1.07

1.2

1.3

5.16

5.09

umol/l

0.07

256

2046

Senile cataract

110

556

1.20

1.06

1.3

2.41

3.31

umol/l

2.43

100

483

Spontaneous abortion

257

1530

1.13

1.06

1.2

1.3

5.31

5.40

umol/l

0.16

232

1390

Sensorineural hearing loss

174

1004

1.16

1.06

1.3

3.04

3.95

umol/l

3.21

150

886

Other benign neoplasms of uterus

1.93

1.06

1.3

1.4

3.20

3.39

umol/l

—

Paroxysmal tachycardia

545

1.24

1.06

1.2

1.3

3.03

5.38

umol/l

7.43

486

Internal derangement of knee

122

1021

1.18

1.06

1.3

4.77

5.23

umol/l

0.67

108

915

Fitting and adjustment of other devices

476

1.26

1.05

1.3

1.2

3.22

3.71

umol/l

0.68

418

Other disorders of bone

632

1.24

1.05

1.7

1.3

4.20

5.42

umol/l

2.28

562

Systemic atrophies primarily affecting the central nervous system

1.96

1.03

1.2

1.6

2.00

4.17

umol/l

—

Carcinoma in situ of other and unspecified sites

2.28

1.03

1.0

5.48

1.55

umol/l

—

Excessive vomiting in pregnancy

420

1.29

1.03

1.6

1.3

5.20

5.92

umol/l

0.88

379

Mental and behavioural disorders due to alcohol, excluding acute intoxication

124

1044

1.18

1.02

1.2

1.3

4.38

5.12

umol/l

1.60

106

915

Other disorders of eyelid

657

1.22

1.02

1.2

1.3

3.23

3.59

umol/l

0.42

584

Budesonide

420

1.29

1.02

1.3

3.93

5.42

umol/l

2.42

370

Other disorders of cornea

171

1.46

1.02

1.6

1.3

4.84

4.42

umol/l

0.16

148

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

167

912

1.15

1.01

1.5

1.3

4.08

5.30

umol/l

4.52

145

801

Paracetamol or NSAID medication

326

1.24

1.01

1.8

1.3

5.98

5.80

umol/l

0.15

300

Renal tubulo-interstitial diseases

294

2387

0.90

1.00

1.3

4.06

5.19

umol/l

6.37

269

2127

Colorectal cancer

245

1.37

1.00

1.1

1.3

2.05

3.17

umol/l

2.91

213

Disorders of vitreous body

106

846

1.19

1.00

1.2

1.3

3.03

3.50

umol/l

0.82

756

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

679

1.22

1.00

1.2

1.4

5.01

5.47

umol/l

0.58

609

malignant neoplasm of male genital organs

147

1.39

1.00

1.1

1.2

2.96

3.36

umol/l

0.30

114

Scar conditions and fibrosis of skin

115

1.57

0.99

1.4

1.2

4.92

5.46

umol/l

0.26

105

Other strabismus

108

907

1.19

0.99

1.5

1.4

5.22

5.50

umol/l

0.32

802

Sequelae of injuries, of poisoning and of other consequences of external causes

574

1.24

0.99

1.6

1.3

4.38

5.04

umol/l

0.97

506

Biomechanical lesions, not elsewhere classified

1.71

0.99

1.9

1.2

3.57

4.78

umol/l

0.80

Haemorrhagic and haematological disorders of fetus and newborn

173

1.45

0.98

1.7

3.82

4.54

umol/l

0.66

154

Arthropathy in Crohn disease

2.19

0.98

1.6

1.1

2.44

5.79

umol/l

—

Pregnancy, childbirth and the puerperium

142

861

0.86

0.98

1.2

1.3

6.45

6.18

umol/l

0.37

132

776

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

458

1.27

0.98

1.2

1.4

3.94

4.85

umol/l

1.34

409

Malignant neoplasm of other connective and soft tissue

2.18

0.98

1.0

1.1

2.92

3.83

umol/l

—

Congenital malformations of heart and great arteries

479

1.26

0.98

1.2

1.5

4.25

5.12

umol/l

1.15

431

Colorectal adenocarcinoma

195

1.42

0.98

1.1

1.4

2.23

2.92

umol/l

1.27

169

Parkinson's disease, strict definition, excluding more controls

1.68

0.98

1.6

1.1

3.35

2.61

umol/l

0.65

Ulcerative colitis

747

1.21

0.98

1.3

3.93

5.50

umol/l

3.99

656

Other articular cartilage disorders

0.00

0.97

0.0

1.1

—

4.27

—

Zoster [herpes zoster]

327

1.32

0.97

1.7

1.3

4.41

4.35

umol/l

0.05

290

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

406

2476

1.09

0.96

1.4

1.3

4.44

5.16

umol/l

3.41

358

2199

Chronic nephritic syndrome

1.77

0.94

1.2

1.3

3.84

5.12

umol/l

—

Other specified/unspecified dorsopathies

1.90

0.94

1.7

1.0

2.87

4.78

umol/l

—

Disorders of vitreous body and globe

108

865

1.18

0.94

1.2

1.3

3.11

3.54

umol/l

0.69

773

Synovial cyst of popliteal space [Baker]

1.62

0.93

1.2

3.58

4.24

umol/l

0.28

Melanocytic naevi of other and unspecified parts of face

158

1.46

0.93

1.7

1.3

5.53

5.32

umol/l

0.11

140

Assault by unspecified means

1.83

0.92

1.3

1.2

4.16

6.33

umol/l

—

Other and unspecified diseases of blood and blood-forming organs

2.15

0.91

1.5

1.2

2.10

5.13

umol/l

—

Pustulosis palmaris et plantaris

1.67

0.91

1.2

1.3

3.84

4.99

umol/l

0.63

Fall on same level involving ice and snow

207

1843

1.12

0.91

1.4

1.3

4.68

5.09

umol/l

0.83

176

1640

Psoriasis

672

1.21

0.90

1.2

1.3

4.40

4.65

umol/l

0.21

598

Striking against or struck by other objects

149

1299

1.15

0.90

1.4

1.3

5.40

5.70

umol/l

0.50

130

1153

Appendicitis, broad definition

283

2301

1.10

0.89

1.2

1.3

5.14

5.10

umol/l

0.04

252

2041

Pneumonia, organism unspecified

356

2233

1.09

0.89

1.4

1.3

4.31

5.07

umol/l

3.55

317

1981

Gout

224

1.34

0.89

1.0

1.1

2.62

3.59

umol/l

1.28

191

IBD patients in KELA-register

802

1.19

0.88

1.3

4.07

5.73

umol/l

4.81

708

Malignant neoplasm of prostate

133

1.38

0.88

1.2

1.1

3.02

3.01

umol/l

0.01

104

Seborrhoeic keratosis

350

1.29

0.88

1.2

1.3

3.18

3.35

umol/l

0.15

308

Left bundle-branch block

1.65

0.88

1.3

1.4

3.46

3.47

umol/l

0.01

Glaucoma-related operations

1.79

0.87

1.7

1.2

3.67

3.27

umol/l

—

Ulcerative proctitis

169

1.42

0.87

1.2

1.3

3.66

5.82

umol/l

2.61

150

Hepatic failure, not elsewhere classified

1.86

0.87

1.1

2.29

4.29

umol/l

—

Other cataract

520

1.20

0.87

1.4

1.3

2.63

3.65

umol/l

2.43

452

Use of selegiline

2.00

0.87

1.0

1.4

4.45

2.49

umol/l

—

Normal-pressure hydrocephalus

2.00

0.87

1.0

1.4

2.25

2.07

umol/l

—

Intermittent heterotropia

307

1.31

0.86

1.6

1.5

4.97

5.65

umol/l

0.50

275

Strabismus

120

1033

1.16

0.86

1.4

1.3

5.05

5.39

umol/l

0.45

104

919

Simple and mucopurulent chronic bronchitis

1.82

0.86

1.0

1.2

2.89

4.53

umol/l

—

Cerebral palsy

1.68

0.85

1.3

1.4

4.87

5.57

umol/l

0.34

Haemangioma and lymphangioma, any site

221

1.36

0.85

1.4

1.3

4.18

4.94

umol/l

0.53

198

Maltreatment syndromes

204

1.38

0.85

1.7

1.2

5.25

6.29

umol/l

0.58

184

Malignant neoplasm of colon

145

1.45

0.84

1.2

1.3

2.06

3.21

umol/l

1.81

124

Pediculosis, acariasis and other infestations, including avohilmo

788

1.18

0.84

1.4

1.3

6.37

5.91

umol/l

0.54

707

Other acute skin changes due to ultraviolet radiation

1.78

0.84

1.0

1.2

2.86

5.17

umol/l

—

malignant neoplasm of male genital organs, including Hilmo

152

1.34

0.84

1.1

1.2

2.96

3.44

umol/l

0.37

117

Other assisted single delivery

115

0.52

0.83

1.2

5.03

5.62

umol/l

—

103

205

1.34

0.83

1.2

1.3

1.97

1.98

umol/l

0.00

182

Open wound of forearm

257

1.33

0.82

1.3

6.67

5.90

umol/l

0.48

224

Primary open-angle glaucoma

289

1.30

0.82

1.6

1.3

2.43

2.56

umol/l

0.13

259

Inflammatory bowel disease, strict (require KELA)

809

1.18

0.82

1.3

4.07

5.67

umol/l

4.54

715

Abdominal aortic aneurysm (AAA)

1.73

0.81

1.1

2.26

2.18

umol/l

—

Malignant neoplasm of brain, including Hilmo

1.61

0.81

1.1

1.4

4.56

5.07

umol/l

0.17

Pedestrian injured in collision with car, pick-up truck or van

1.71

0.80

1.3

1.1

6.10

6.04

umol/l

—

Contact with sharp glass

122

1.48

0.80

1.1

1.2

6.41

6.24

umol/l

0.09

106

Mental and behavioural disorders due to alcohol

156

1314

1.13

0.80

1.2

1.3

4.66

5.26

umol/l

1.24

136

1157

ILD medications: immunosuppressive drugs

246

2021

1.10

0.80

1.3

4.06

5.16

umol/l

5.39

218

1798

Pneumonias (Asthma/COPD co-morbidities)

419

2536

1.08

0.79

1.4

1.3

4.45

5.22

umol/l

3.88

369

2255

Medical abortion

289

1712

0.91

0.79

1.4

1.3

5.39

5.52

umol/l

0.21

256

1557

Cardiodefibrillation

364

1.26

0.79

1.2

1.96

2.96

umol/l

1.73

309

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

555

1.21

0.79

1.2

1.3

4.33

5.57

umol/l

1.94

488

Glucosamine medication

427

1.22

0.79

1.4

1.3

2.29

2.47

umol/l

0.18

379

Necrosis of pulp, including avohilmo

237

2124

1.10

0.78

1.3

4.73

5.25

umol/l

1.27

202

1884

D07AA Corticosteroids, weak (group I)

710

1.18

0.78

1.3

5.12

5.80

umol/l

0.87

640

Fracture of forearm

174

1749

0.89

0.78

1.3

1.4

4.73

5.16

umol/l

0.79

156

1561

Trigger finger

277

1.30

0.78

1.7

1.2

3.71

4.35

umol/l

0.54

244

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

510

1.22

0.78

1.2

1.3

4.26

5.58

umol/l

2.06

448

Non-rheumatic valve diseases

591

1.17

0.78

1.3

3.01

4.00

umol/l

2.69

522

Mental disorders, not otherwise specified

313

1.28

0.77

1.9

1.3

5.30

5.82

umol/l

0.40

283

Acute appendicitis, no complications

221

1987

1.11

0.77

1.2

1.3

4.87

5.25

umol/l

0.90

194

1756

Malignant neoplasm of digestive organs, including Hilmo

407

1.21

0.77

1.2

1.3

2.40

3.19

umol/l

1.58

350

Other and unspecified iron deficiency

110

951

1.16

0.77

1.2

1.3

3.85

4.94

umol/l

2.93

851

Ulcerative colitis (strict definition, require KELA)

529

1.21

0.77

1.2

1.3

4.35

5.58

umol/l

1.82

465

Neonatal jaundice from other and unspecified causes

144

1.43

0.77

1.9

1.8

3.30

4.18

umol/l

0.88

127

Sulfonylureas

206

1.31

0.76

1.2

1.3

2.50

2.63

umol/l

0.08

170

Focal epilepsy

575

1.20

0.76

1.5

1.4

4.89

4.88

umol/l

0.01

504

Other diseases of peritoneum

1.70

0.76

2.0

1.3

3.01

4.50

umol/l

—

Pedestrian injured in collision with pedal cycle

1.70

0.75

3.0

1.2

2.65

5.16

umol/l

—

Malignant neoplasm of prostate, including Hilmo

137

1.34

0.75

1.2

1.1

3.02

3.03

umol/l

0.01

107

Separation of retinal layers (serosa)

1.70

0.75

1.1

1.4

4.11

4.95

umol/l

—

Ulcerative colitis, NAS

395

1.24

0.75

1.3

3.35

5.48

umol/l

5.88

349

Subacute thyroiditis

1.65

0.75

2.1

1.2

3.84

5.52

umol/l

1.42

Normotensive glaucoma

1.64

0.75

1.5

1.4

2.28

2.26

umol/l

0.01

Acute appendicitis

265

2248

1.09

0.75

1.2

1.3

4.93

5.11

umol/l

0.35

234

1993

Malignant neoplasm of digestive organs

356

1.22

0.75

1.1

1.3

2.32

3.18

umol/l

1.64

304

Other and unspecified injuries of ankle and foot

175

1.38

0.74

1.1

1.3

7.54

5.62

umol/l

0.91

157

Excessive earwax

187

1523

1.11

0.74

1.3

5.17

4.64

umol/l

1.02

164

1349

Respiratory and cardiovascular disorders specific to the perinatal period

211

1.32

0.73

1.8

1.6

4.41

5.01

umol/l

0.39

190

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

251

1736

0.91

0.73

1.4

1.3

3.90

4.54

umol/l

2.33

215

1527

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

419

2465

1.07

0.72

1.5

1.3

4.36

5.27

umol/l

5.71

373

2198

Unspecified dementia

1.62

0.72

1.1

2.64

2.16

umol/l

—

Other specified/unspecified disorders of bone/cartilage

1.80

0.72

1.9

1.1

4.43

5.43

umol/l

—

Enteropathic arthropathies

1.61

0.72

1.7

1.2

2.62

5.72

umol/l

—

Manic episode

1.67

0.72

1.2

1.1

4.42

6.29

umol/l

—

Undefined dementia

1.60

0.71

1.1

1.3

2.64

2.21

umol/l

—

All pneumoniae

421

2549

1.07

0.71

1.4

1.3

4.46

5.22

umol/l

3.82

371

2268

Atopic conjunctivitis

168

1.37

0.71

1.1

1.3

4.13

5.98

umol/l

1.38

153

Other protozoal intestinal diseases, including avohilmo

1.58

0.71

1.3

1.1

4.97

6.67

umol/l

—

Brain meningioma

1.58

0.71

1.2

1.5

1.46

3.74

umol/l

—

Vitiligo

1.93

0.71

2.8

1.2

8.54

5.43

umol/l

—

Parkinson's disease, excluding more controls

1.52

0.70

1.6

1.1

3.35

2.67

umol/l

0.59

Coxarthrosis [arthrosis of hip](FG)

570

1.16

0.70

1.1

1.3

2.86

3.52

umol/l

1.00

497

Pyothorax

1.67

0.68

1.1

1.4

3.13

4.83

umol/l

—

Brain meningioma, including Hilmo

1.53

0.68

1.2

1.6

1.46

3.67

umol/l

—

Acute tubulo-interstitial nephritis

208

1927

0.91

0.68

1.3

4.48

5.31

umol/l

2.60

190

1707

Seropositive rheumatoid arthritis, wide

475

0.80

0.68

1.3

2.39

3.96

umol/l

3.52

424

Slow fetal growth and fetal malnutrition

1.65

0.68

1.6

1.4

4.29

3.92

umol/l

—

Attention to artificial openings

1.63

0.67

1.0

1.3

4.11

3.95

umol/l

—

Coxarthrosis

483

1.16

0.66

1.1

1.2

2.98

3.69

umol/l

0.99

428

Malignant neoplasm of oral cavity

1.79

0.66

1.0

1.2

3.00

3.79

umol/l

—

Cerebrovascular diseases

118

926

0.88

0.66

1.2

1.3

2.81

3.65

umol/l

2.65

102

806

Rheumatoid arthritis

593

0.84

0.65

1.2

1.3

3.15

4.50

umol/l

2.59

533

Presbycusis

1.51

0.65

1.1

1.3

1.42

2.11

umol/l

0.87

Other puerperal infections

559

1.18

0.65

1.3

1.2

5.27

6.30

umol/l

1.97

512

Other disorders of ear

302

1805

1.08

0.65

1.4

1.3

4.08

4.76

umol/l

2.32

263

1599

Liquid cancers

424

1.21

0.65

1.1

1.3

2.53

3.96

umol/l

3.32

371

Protozoal diseases, including avohilmo

1.59

0.65

2.9

1.3

2.14

4.81

umol/l

—

Bleeding

231

1482

1.09

0.65

1.3

1.4

3.98

4.50

umol/l

0.64

206

1298

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

120

1.42

0.64

1.0

1.4

3.60

4.85

umol/l

1.37

111

Diseases of pulp and periapical tissues and dental caries

197

916

1.10

0.64

1.3

4.82

4.79

umol/l

0.04

174

805

Unspecified visual impairment (binocular)

1.73

0.64

2.0

1.2

5.28

4.01

umol/l

—

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

1.73

0.64

1.4

1.1

3.10

5.22

umol/l

—

Injuries to the head

475

2650

1.06

0.64

1.3

4.90

5.27

umol/l

1.35

418

2371

Degeneration of macula and posterior pole

431

1.18

0.63

1.3

1.2

2.65

2.75

umol/l

0.12

382

All-cause Heart Failure

491

1.16

0.63

1.3

1.2

2.53

3.14

umol/l

1.20

420

Herpesviral [herpes simplex] infections

323

1.24

0.63

1.2

1.3

3.83

5.26

umol/l

1.71

290

Alcohol use disorder, Swedish definition

155

1268

1.11

0.63

1.2

1.3

4.33

5.07

umol/l

1.95

135

1109

Other/unspecified seropositive rheumatoid arthritis

470

0.81

0.63

1.3

2.39

3.94

umol/l

3.44

419

Periapical abscess

145

1302

1.11

0.63

1.2

1.4

4.35

4.86

umol/l

0.92

129

1135

LSIL lesion of the cervix uteri, vagina or vulva

691

1.16

0.63

1.5

1.3

4.98

5.48

umol/l

0.69

630

Pre-eclampsia

102

897

1.14

0.62

1.4

1.3

5.11

5.27

umol/l

0.18

800

Malignant neoplasm of ovary, including Hilmo

104

1.44

0.62

1.3

1.5

2.85

3.84

umol/l

0.72

Valvular heart disease excluding rheumatic fever

612

1.14

0.62

1.3

2.98

3.97

umol/l

2.72

540

Lichen planus, including avohilmo

324

1.24

0.62

1.4

1.3

4.08

3.80

umol/l

0.16

285

Other congenital malformations of intestine, including avohilmo

1.67

0.61

1.0

1.4

4.32

4.04

umol/l

—

Bacterial, viral and other infectious agents, including avohilmo

235

1.28

0.61

1.6

1.3

5.41

5.27

umol/l

0.06

208

Viral conjunctivitis

1.57

0.60

1.3

1.2

3.92

6.32

umol/l

—

Malignant neoplasm of corpus uteri

1.48

0.60

1.2

1.5

3.45

2.21

umol/l

0.65

Other specified/unspecified arthritis

741

1.15

0.60

1.3

3.56

5.12

umol/l

4.22

670

Zoster [herpes zoster], including avohilmo

146

1270

1.11

0.60

1.4

1.3

3.96

4.57

umol/l

1.47

129

1127

Superficial injury of thorax

344

1.22

0.59

1.2

1.3

4.61

5.30

umol/l

0.60

304

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

1.52

0.58

1.3

1.7

5.55

4.76

umol/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

465

0.82

0.58

1.3

2.39

3.94

umol/l

3.43

416

Malignant neoplasm of oesophagus, including Hilmo

0.00

0.58

0.0

1.3

—

3.70

—

Malignant neoplasm of pancreas

1.51

0.58

1.0

1.3

2.99

2.87

umol/l

—

Hard cardiovascular diseases

207

1120

1.09

0.58

1.3

1.4

2.75

3.90

umol/l

6.81

182

974

Pedal cyclist injured in noncollision transport accidents

327

1.22

0.58

1.8

1.3

4.36

5.64

umol/l

1.48

292

Crushed, pushed or stepped on by crowd or human stampede

300

1.24

0.58

1.3

5.58

6.20

umol/l

0.40

268

Pustular psoriasis

1.46

0.58

1.2

1.4

3.84

4.85

umol/l

0.55

therapeutic use

1.72

0.57

2.2

1.4

3.33

4.13

umol/l

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

106

1.42

0.57

1.6

1.4

4.15

4.80

umol/l

0.26

Certain zoonotic bacterial diseases, including avohilmo

1.48

0.57

1.9

1.4

4.71

5.48

umol/l

—

Suppurative and necrotic conditions of lower respiratory tract

1.48

0.57

1.3

1.6

3.70

4.29

umol/l

—

Other and unspecified anaemias

681

1.14

0.56

1.2

1.3

2.79

4.03

umol/l

4.40

599

Primary coxarthrosis, bilateral

310

1.23

0.56

1.1

1.3

2.31

2.75

umol/l

0.54

271

Behavioural disorders, excluding more controls

1.48

0.56

1.3

1.5

4.97

5.87

umol/l

0.33

Heart failure, strict

503

1.15

0.56

1.3

1.2

2.53

3.14

umol/l

1.20

429

Hallux valgus (acquired)

498

1.15

0.56

1.4

1.3

3.19

4.15

umol/l

1.96

455

Conductive and sensorineural hearing loss

194

1180

1.09

0.56

1.3

3.28

4.20

umol/l

3.30

167

1045

Unspecified acute lower respiratory infection

338

1.21

0.55

1.7

1.3

4.67

5.05

umol/l

0.24

294

Acquired haemolytic anaemia

1.63

0.55

1.0

1.4

2.95

5.07

umol/l

—

Open wound of lower leg

393

1.20

0.55

1.1

1.3

4.60

5.37

umol/l

0.81

350

Ulcerative rectosigmoiditis

203

1.28

0.55

1.2

1.3

3.80

5.45

umol/l

2.17

182

Inflammatory disorders of breast

357

1.21

0.55

1.5

1.2

5.24

6.22

umol/l

0.84

324

Childhood allergy (age < 16)

164

1233

1.10

0.55

1.2

1.3

5.77

6.82

umol/l

3.01

148

1132

Unspecified abortion

123

0.65

0.54

1.3

1.4

2.58

4.44

umol/l

—

113

Endocarditis

1.58

0.54

1.0

1.4

3.25

5.13

umol/l

—

Bacterial, viral and other infectious agents

204

1.28

0.54

1.6

1.4

5.07

5.29

umol/l

0.10

181

Ulcerative colitis (strict definition, all Crohn cases excluded)

423

1.18

0.53

1.3

4.50

5.51

umol/l

0.99

376

Other anaemias

692

1.14

0.53

1.2

1.3

2.82

4.04

umol/l

4.34

609

Other bacterial diseases, including avohilmo

382

2247

1.06

0.52

1.3

4.22

5.06

umol/l

4.31

336

1991

Other congenital malformations of tongue, mouth and pharynx

0.61

0.52

3.2

1.5

4.54

5.30

umol/l

—

All chronic kidney diseases

148

1074

1.10

0.51

1.4

1.3

3.77

4.67

umol/l

2.62

135

949

Liquid cancers, including Hilmo

496

1.16

0.51

1.1

1.3

2.41

3.94

umol/l

4.60

428

Malignant neoplasm of corpus uteri, including Hilmo

100

1.40

0.51

1.1

1.5

3.28

2.34

umol/l

0.48

Cardiomyopathy, other and unspecified

100

0.60

0.51

2.5

1.3

3.37

4.50

umol/l

—

Primary_lymphoid and hematopoietic malignant neoplasms

360

1.20

0.51

1.1

1.3

2.46

4.02

umol/l

3.51

315

Retinal detachments and breaks

508

1.16

0.51

1.4

1.3

3.13

3.51

umol/l

0.46

449

Injuries to the shoulder and upper arm

292

2109

1.07

0.51

1.4

1.3

4.51

5.05

umol/l

1.64

256

1868

Myeloproliferative diseases

1.41

0.50

1.0

1.3

2.64

4.15

umol/l

—

Diffuse large B-cell lymphoma

1.46

0.50

1.2

1.4

1.94

4.02

umol/l

—

Diffuse large B-cell lymphoma, helper endpoint

1.46

0.50

1.2

1.4

1.94

4.02

umol/l

—

Diffuse large B-cell lymphoma, including Hilmo

1.46

0.50

1.2

1.4

1.94

4.02

umol/l

—

L04AA Selective immunosuppressants

617

0.86

0.50

1.4

3.62

4.78

umol/l

1.84

545

Covid-19 suspected case

106

954

1.11

0.49

1.4

1.3

5.53

5.82

umol/l

0.29

854

Other arthritis (FG)

861

1.12

0.47

1.3

3.54

5.08

umol/l

5.10

774

Twin gestation

452

0.84

0.47

1.5

1.3

4.81

5.45

umol/l

0.77

404

Maternal care for known or suspected abnormality of pelvic organs

170

1057

1.09

0.47

1.2

1.3

5.61

5.73

umol/l

0.17

157

952

Acute alcohol intoxication

597

1.14

0.47

1.3

5.02

5.36

umol/l

0.29

527

Placenta praevia

244

0.78

0.47

1.7

1.2

5.07

5.70

umol/l

0.59

218

Scabies, including avohilmo

720

1.13

0.46

1.4

1.3

6.61

6.03

umol/l

0.63

644

Unspecified fall

176

1597

1.08

0.46

1.3

5.50

5.16

umol/l

0.24

146

1422

Heart failure and coronary heart disease

306

1.17

0.46

1.3

2.26

3.11

umol/l

1.66

255

Alcohol dependence

439

1.16

0.46

1.3

2.75

4.53

umol/l

5.01

379

Routine general health check-up of defined subpopulation

1.43

0.46

1.0

1.1

5.11

5.62

umol/l

—

Cerebrovascular diseases (FINNGEN)

438

1.14

0.45

1.2

1.3

3.01

4.57

umol/l

5.37

378

Pre-eclampsia or eclampsia

103

931

1.11

0.45

1.4

1.3

5.08

5.22

umol/l

0.16

832

Gestational [pregnancy-induced] hypertension

150

1378

1.09

0.45

1.3

5.58

5.54

umol/l

0.05

140

1240

412

1.16

0.45

1.3

1.2

1.87

2.88

umol/l

2.30

363

All dysplastic lesions of the cervix uteri, vagina or vulva

172

1553

1.08

0.45

1.4

1.3

5.49

5.43

umol/l

0.09

155

1398

Gout, FINNGEN

290

1.20

0.45

1.0

1.3

2.62

3.30

umol/l

0.80

242

Hemiplegia

1.40

0.44

1.2

1.3

3.45

5.43

umol/l

2.02

Bicuspidal aortic valve syndrome

1.45

0.44

1.0

1.3

3.60

5.73

umol/l

—

Pneumonitis due to solids and liquids

1.45

0.44

2.1

1.3

3.75

3.89

umol/l

—

Asymmetry of jaw

1.38

0.44

1.7

1.4

3.59

6.04

umol/l

—

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

126

0.71

0.43

2.9

1.5

3.89

5.08

umol/l

—

113

Diabetic retinopathy, strict definition

559

0.87

0.43

1.5

1.3

4.19

5.17

umol/l

1.54

516

Maternal care for known or suspected disproportion

174

0.75

0.43

1.1

1.3

3.76

5.13

umol/l

1.13

156

Other and unspecified disorders of vitreous body

671

1.12

0.43

1.2

1.3

2.71

3.18

umol/l

0.72

592

Leiomyoma of uterus

205

1071

1.07

0.43

1.3

3.64

4.25

umol/l

1.94

183

956

Other disorders of optic disc

1.62

0.43

1.2

5.38

5.37

umol/l

—

Myeloproliferative diseases (CML excluded)

1.41

0.43

1.0

1.3

3.13

4.08

umol/l

—

Malignant neoplasm of brain

1.43

0.42

1.1

1.5

6.09

5.41

umol/l

—

Superficial injury of wrist and hand

101

916

1.10

0.42

1.2

1.3

5.81

5.82

umol/l

0.01

819

Other specific arthropathies, wide

1.57

0.42

1.6

1.1

7.46

5.71

umol/l

—

Respiratory distress of newborn

138

1.29

0.42

2.0

1.9

3.64

3.72

umol/l

0.05

121

Maternal care for known or suspected malpresentation of fetus

144

946

1.09

0.42

1.2

1.3

5.33

5.91

umol/l

1.45

131

854

Personal history of allergy to drugs, medicaments and biological substances

1.52

0.41

3.2

1.4

2.97

6.18

umol/l

—

Renal agenesis and other reduction defects of kidney, including avohilmo

0.00

0.41

0.0

1.0

—

6.12

—

Alcohol use disorder, ICD-based

107

975

1.10

0.41

1.2

1.3

4.40

5.15

umol/l

1.39

855

Malignant neoplasm of oesophagus

0.00

0.41

0.0

1.3

—

3.63

—

Tetralogy of Fallot, a congenital heart defect.

0.00

0.41

0.0

1.1

—

4.88

—

Other specified and unspecified disorders of eye and adnexa

1.36

0.41

2.3

1.1

3.66

5.29

umol/l

—

Other diseases of pericardium

1.36

0.41

2.1

1.4

1.99

4.36

umol/l

—

Patellar tendinitis

1.47

0.40

1.0

1.2

4.70

6.58

umol/l

—

Cardiomyopathies, Primary/intrinsic

138

0.72

0.40

1.2

1.4

2.64

4.12

umol/l

—

121

Degeneration of nervous system due to alcohol

0.00

0.40

0.0

1.1

—

3.34

—

Peritonsillar abscess

758

1.11

0.39

1.3

1.2

5.62

5.74

umol/l

0.11

670

Speech therapy

512

1.13

0.39

1.4

1.3

4.21

4.28

umol/l

0.06

450

Degeneration of the brain due to alcohol

0.00

0.39

0.0

1.1

—

3.41

—

Supervision of normal pregnancy

126

781

0.92

0.39

1.2

1.3

6.09

6.11

umol/l

0.02

114

706

Other congenital malformations of ear

1.38

0.38

1.0

1.2

6.30

6.68

umol/l

0.13

Struck by thrown, projected or falling objec

124

1.29

0.38

1.7

1.1

5.22

5.93

umol/l

0.33

107

Other inflammation of vagina/vulva

160

1.25

0.38

2.1

1.2

4.31

5.89

umol/l

1.46

148

Juvenile rheumatoid arthirtis

1.38

0.38

1.9

1.3

4.46

5.90

umol/l

0.84

Infliximab

1.37

0.38

1.1

1.2

2.86

6.34

umol/l

—

Stroke, including SAH

696

0.91

0.38

1.2

1.3

2.48

3.39

umol/l

3.10

604

Exposure to other specified electric current

1.33

0.37

1.3

1.2

7.46

6.44

umol/l

—

Other disorders of kidney and ureter

188

1.22

0.37

1.6

1.4

2.34

4.20

umol/l

3.63

161

Other (seronegative) rheumatoid arthritis, wide

344

0.84

0.37

1.3

3.86

4.18

umol/l

0.22

310

Other and unspecified mononeuropathies, also in other diseases

1.35

0.37

1.0

1.1

3.48

3.78

umol/l

—

Malignant neoplasm of eye, brain and central nervous system

1.39

0.37

1.9

1.4

5.16

4.96

umol/l

—

Pregnancy with abortive outcome

352

1748

1.05

0.37

1.2

1.3

5.73

5.58

umol/l

0.31

321

1591

Alzheimer’s disease (Late onset)

121

0.75

0.36

1.0

1.3

2.61

1.82

umol/l

0.91

105

Unstable angina pectoris

293

1.15

0.36

1.0

1.3

1.52

3.10

umol/l

6.21

244

Congenital malformations of great arteries

123

1.28

0.36

1.1

1.8

4.86

3.96

umol/l

0.56

109

Skin changes due to chronic exposure to nonionizing radiation

364

1.14

0.36

1.4

1.2

1.68

2.47

umol/l

1.51

319

Multiple gestation

460

0.87

0.36

1.5

1.3

4.96

5.44

umol/l

0.52

410

Malignant neoplasm of breast, HER-positive

485

0.89

0.36

1.1

1.5

2.59

3.41

umol/l

1.45

432

Labour and delivery complicated by fetal stress [distress]

191

1166

1.07

0.36

1.3

5.73

6.03

umol/l

0.60

178

1047

Complications predominantly related to the puerperium

148

1380

1.07

0.35

1.5

1.3

4.66

5.64

umol/l

3.32

137

1254

Injury of nerves at wrist and hand level

0.64

0.35

1.0

1.2

7.68

5.56

umol/l

—

Venous complications and haemorrhoids in pregnancy

0.63

0.35

1.0

1.2

7.08

5.98

umol/l

—

Abnormal findings on antenatal screening of mother

660

0.89

0.35

1.3

5.80

6.28

umol/l

0.44

601

Conduct disorder

1.32

0.35

1.8

1.5

4.67

5.79

umol/l

0.46

L04AX Other immunosuppressants

197

1854

1.06

0.35

1.3

3.89

4.92

umol/l

3.96

175

1637

Protozoal diseases

1.40

0.35

3.2

1.3

1.98

4.74

umol/l

—

Seropositive rheumatoid arthritis

435

0.87

0.35

1.3

2.39

4.29

umol/l

4.16

394

Sulfasalazine

806

0.91

0.35

1.2

1.3

4.57

5.12

umol/l

0.63

718

Birth asphyxia

1.37

0.34

1.5

1.4

3.52

4.73

umol/l

—

Use of anticholinesterases

210

1.18

0.34

1.0

1.3

2.89

2.12

umol/l

1.12

182

N06DA Anticholinesterases

210

1.18

0.34

1.0

1.3

2.89

2.12

umol/l

1.12

182

Chondromalacia

1.37

0.34

1.2

1.1

5.20

6.11

umol/l

—

Presence of cardiac and vascular implants and grafts

392

0.88

0.34

1.0

1.3

2.00

3.39

umol/l

3.83

337

Umbilical hernia

604

1.11

0.34

1.6

1.3

5.79

4.87

umol/l

0.31

523

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

129

1200

1.08

0.34

1.3

6.53

6.14

umol/l

0.60

116

1076

Bell's palsy

246

1.18

0.34

1.1

1.3

5.83

4.87

umol/l

0.60

217

Basal cell carcinoma

391

0.89

0.33

1.6

1.3

2.25

3.10

umol/l

2.10

333

Pre-eclampsia or poor fetal growth

176

1650

1.06

0.33

1.4

1.3

5.26

5.57

umol/l

0.65

158

1490

Suggestive for eosinophilic asthma

143

0.77

0.32

1.6

1.2

2.50

4.73

umol/l

2.59

123

Malignant neoplasm of breast, ER-positive, including Hilmo

487

0.90

0.31

1.1

1.5

2.61

3.40

umol/l

1.42

434

Injuries to the hip and thigh

120

1001

1.07

0.31

1.4

1.3

5.08

4.80

umol/l

0.31

104

881

L04AC Interleukin inhibitors

174

1.21

0.31

1.3

5.13

5.22

umol/l

0.03

156

Any event in cancer register

331

2016

0.96

0.31

1.4

1.3

4.14

5.14

umol/l

5.39

293

1785

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

645

1.10

0.31

1.2

1.4

4.81

5.40

umol/l

0.69

580

Solid cancers, including Hilmo

265

1471

1.05

0.31

1.4

1.3

3.59

4.65

umol/l

5.27

236

1286

Disorders of choroid and retina

192

1270

1.06

0.31

1.4

1.3

3.59

4.25

umol/l

2.00

168

1117

Acute and subacute iridocyclitis

437

1.12

0.31

1.5

1.3

3.99

4.88

umol/l

0.82

387

Disorders in reading

102

1.28

0.30

1.2

1.5

5.70

5.43

umol/l

0.07

Parkinson's disease, strict definition

111

1.26

0.30

1.6

1.4

3.35

2.56

umol/l

0.79

Carcinoma in situ of breast, intraductal

130

0.77

0.29

1.0

1.5

2.49

3.50

umol/l

—

116

Other disorders of veins

946

0.93

0.29

1.2

1.3

3.96

4.11

umol/l

0.15

831

All kidney diseases

379

2631

0.96

0.28

1.3

4.23

5.30

umol/l

7.15

344

2337

Type 1 diabetes, strict definition, subgroup 1

354

1.13

0.28

1.3

1.4

4.56

5.40

umol/l

1.23

312

Second line medication for Crohn's disease

207

1970

1.05

0.27

1.3

3.89

5.01

umol/l

4.89

184

1733

Basal cell carcinoma, including Hilmo

418

0.91

0.27

1.5

1.4

2.30

3.37

umol/l

2.35

360

Ankyloglossia

120

0.74

0.27

2.9

1.5

3.89

5.22

umol/l

—

109

Alzheimer’s disease, strict definition

139

0.81

0.27

1.1

1.3

3.72

1.91

umol/l

1.12

122

Seronegative juvenile rheumatoid arthritis

104

1.25

0.26

1.7

1.3

5.01

5.59

umol/l

0.25

Major coronary heart disease event excluding revascularizations

506

1.08

0.26

1.0

1.3

1.71

3.25

umol/l

11.31

432

Type 1 diabetes, definitions combined

413

1.11

0.26

1.5

1.4

4.54

5.37

umol/l

1.27

361

Ascites

1.30

0.26

1.2

1.3

3.03

3.68

umol/l

—

LSIL lesion of the cervix uteri

607

1.09

0.25

1.4

1.3

5.34

5.75

umol/l

0.45

553

Type 1 diabetes, strict (exclude DM2)

414

1.11

0.25

1.5

1.4

4.54

5.37

umol/l

1.25

362

Blepharochalasis

377

1.11

0.25

1.3

2.96

3.08

umol/l

0.07

336

Monoarthritis, not elsewhere classified

1.22

0.25

1.0

1.1

3.40

5.36

umol/l

—

Other heart diseases

190

1177

1.05

0.25

1.4

1.3

4.07

5.47

umol/l

6.22

162

1035

Hordeolum and other deep inflammation of eyelid

170

1.18

0.24

1.2

1.3

5.25

5.29

umol/l

0.02

151

Non-follicular lymphoma

1.25

0.24

1.1

1.3

1.89

3.77

umol/l

3.63

Benign neoplasm of other and unspecified female genital organs

1.17

0.24

1.3

1.4

4.88

5.02

umol/l

—

Motorcycle rider injured in noncollision transport accidents

0.73

0.24

1.2

1.3

5.75

6.98

umol/l

—

Aplastic and other anaemias

760

1.07

0.24

1.2

1.3

3.03

4.07

umol/l

2.99

670

Reimbursement for rheumatic diseases

164

1710

0.95

0.24

1.3

3.82

4.79

umol/l

3.20

145

1514

Car occupant injured in other and unspecified transport accidents

755

1.07

0.23

1.3

5.35

5.92

umol/l

0.73

671

Actinic keratosis

345

1.11

0.23

1.4

1.2

1.55

2.39

umol/l

1.71

304

malignant neoplasm of female genital organs

241

1.14

0.23

1.4

4.04

3.58

umol/l

0.32

223

Solid cancers

245

1380

1.04

0.23

1.4

1.3

3.55

4.54

umol/l

4.37

217

1206

All dysplastic lesions of the cervix uteri

158

1482

1.05

0.23

1.4

1.3

5.64

5.55

umol/l

0.12

144

1329

Burn and corrosion of head and neck

1.28

0.23

1.0

1.2

5.22

5.90

umol/l

—

Sequelae of cerebrovascular disease

377

0.91

0.22

1.2

3.06

3.20

umol/l

0.12

325

Melanoma in situ

1.22

0.22

1.0

1.3

1.74

3.92

umol/l

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

0.21

0.0

1.3

—

4.69

—

Otosclerosis

102

0.78

0.21

1.1

1.3

3.88

4.08

umol/l

—

Fracture of skull and facial bones

546

1.08

0.21

1.6

1.3

4.64

5.20

umol/l

0.51

481

Malignant neoplasm

260

1469

1.04

0.21

1.4

1.3

3.58

4.64

umol/l

5.08

226

1283

Complications of anaesthesia during the puerperium

0.00

0.21

0.0

1.2

—

8.41

—

severe traumatic brain injury, does not include concussion

287

1.12

0.20

1.0

1.4

3.91

4.26

umol/l

0.23

245

Dilated cardiomyopathy

115

0.78

0.20

1.2

1.3

2.90

3.69

umol/l

—

Macular hole

1.20

0.19

1.5

1.3

3.67

2.15

umol/l

—

Carcinoma in situ of cervix uteri

644

0.93

0.19

1.1

1.3

6.37

6.06

umol/l

0.26

585

Fetus and newborn affected by maternal complications of pregnancy

1.16

0.19

1.8

1.7

4.49

4.15

umol/l

—

Chronic apical periodontitis

445

2433

1.03

0.19

1.3

4.86

5.39

umol/l

2.15

394

2171

Hernia

286

1842

1.03

0.18

1.3

4.01

4.68

umol/l

1.12

249

1614

Polypectomy (DHB20)

1.24

0.18

1.4

1.3

3.71

5.04

umol/l

—

Periodontal disease, other/unspecified

1.13

0.18

1.7

1.0

4.01

5.11

umol/l

—

Meniscus derangement

116

733

1.05

0.18

1.4

1.3

3.31

4.32

umol/l

2.42

106

648

Iridocyclitis

541

1.07

0.18

1.4

1.3

3.72

4.83

umol/l

1.45

478

171

1469

1.04

0.18

1.2

1.3

4.64

5.29

umol/l

1.52

150

1289

Caught, crushed, jammed or pinched in or between objects

153

0.85

0.18

2.0

1.3

4.02

5.82

umol/l

0.98

136

Obstructed labour due to malposition and malpresentation of fetus

114

1106

0.95

0.18

1.2

1.3

5.32

5.48

umol/l

0.21

105

991

183

1534

1.04

0.17

1.2

1.3

4.60

5.30

umol/l

1.83

161

1346

Myocardial infarction

398

1.07

0.17

1.0

1.2

1.81

3.33

umol/l

8.97

337

Asthma/COPD (KELA code 203)

388

2529

1.02

0.17

1.4

1.3

4.32

5.43

umol/l

3.71

346

2267

Acute alcohol intoxication, ICD10

552

1.07

0.17

1.3

5.36

5.71

umol/l

0.26

488

Impacted maxillary canine

0.74

0.17

1.2

1.6

7.06

5.81

umol/l

—

Finngen Rheumatological endpoints

404

2239

1.02

0.16

1.4

1.3

4.39

5.58

umol/l

8.48

341

2012

Recurrent dislocation of patella

292

1.10

0.16

1.4

1.2

6.62

6.32

umol/l

0.16

268

Carrier of infectious disease

1.14

0.16

1.4

1.1

2.50

5.83

umol/l

—

Malignant neoplasm of skin

515

0.95

0.15

1.4

2.54

3.59

umol/l

2.69

452

Stroke, excluding SAH

630

0.95

0.15

1.2

2.38

3.41

umol/l

3.68

542

Anisometropia and aniseikonia

1.21

0.15

1.5

1.3

4.85

4.84

umol/l

—

Injuries to the elbow and forearm

275

2417

0.97

0.15

1.2

1.3

5.16

5.33

umol/l

0.32

247

2161

Parkinson's disease

121

1.16

0.15

1.6

1.4

3.35

2.58

umol/l

0.75

105

Septal defects

298

1.09

0.14

1.2

1.6

3.84

4.74

umol/l

0.80

268

Duodenal ulcer

0.82

0.13

1.0

1.3

2.08

3.60

umol/l

—

Fibrosis and cirrhosis of liver

0.81

0.13

1.0

1.3

1.60

4.01

umol/l

—

Corneal ulcer

519

1.06

0.13

1.2

1.3

5.33

5.28

umol/l

0.03

460

Malignant neoplasm

258

1473

1.03

0.13

1.4

1.3

3.59

4.66

umol/l

5.10

224

1287

Type 1 diabetes, strict definition

372

1.07

0.13

1.3

1.4

4.56

5.34

umol/l

1.10

327

Ischaemic Stroke, excluding all haemorrhages

564

0.95

0.13

1.2

1.3

2.39

3.32

umol/l

2.87

486

Other hammer toe(s) (acquired)

172

1.11

0.13

1.1

1.2

2.86

3.14

umol/l

0.15

154

Benign mammary dysplasia

286

1.08

0.13

1.7

1.3

2.80

4.39

umol/l

2.30

261

Anterior Iridocyclitis

471

1.06

0.13

1.5

1.3

3.97

4.91

umol/l

0.92

414

Rheumatoid arthritis, including avohilmo

857

0.96

0.13

1.2

1.4

3.56

4.28

umol/l

1.37

772

Maternal care for other conditions predominantly related to pregnancy

131

1235

1.03

0.12

1.3

5.18

5.75

umol/l

1.16

119

1110

Coxarthrosis, primary, with hip surgery

528

1.05

0.12

1.2

1.3

2.67

2.70

umol/l

0.02

457

Biological medication for rheuma

668

1.05

0.12

1.4

1.3

4.41

5.55

umol/l

1.94

595

Maternal care for known or suspected fetal abnormality and damage

106

931

0.96

0.12

1.2

1.3

6.05

5.95

umol/l

0.11

839

Other heart diseases, wide

357

2200

0.98

0.12

1.3

4.06

5.28

umol/l

8.45

312

1964

Embedded teeth, including avohilmo

610

0.95

0.12

1.5

1.2

5.67

6.63

umol/l

1.25

554

Artificial joint operation, meniscal resection

194

1271

0.98

0.11

1.3

3.15

4.11

umol/l

3.28

169

1107

Malignant neoplasm, wide definition

276

1573

1.02

0.11

1.4

1.3

3.63

4.75

umol/l

5.98

242

1378

Congenital malformations of cardiac septa

308

1.07

0.11

1.2

1.5

3.84

4.96

umol/l

1.08

278

Varicose veins

122

893

1.03

0.10

1.4

1.3

2.82

3.57

umol/l

1.77

102

787

Myocardial infarction, without ST-elevation

349

1.06

0.10

1.0

1.2

1.65

2.82

umol/l

5.29

295

Malignant neoplasm, including Hilmo

276

1576

1.02

0.10

1.4

1.3

3.63

4.76

umol/l

6.10

242

1381

L02BA Anti-estrogens

331

0.94

0.10

1.2

1.4

3.14

3.55

umol/l

0.32

298

Behavioural disorders

106

1.13

0.10

1.3

1.4

4.98

6.21

umol/l

0.50

Chronic iridocyclitis

106

1.13

0.09

1.2

4.82

5.42

umol/l

0.18

Disorders resulting from impaired renal tubular function

1.09

0.09

1.4

1.1

1.86

4.36

umol/l

—

Pericarditis

1.09

0.09

2.8

1.5

2.72

4.85

umol/l

—

L01XE Protein kinase inhibitors

1.04

0.09

1.0

1.3

1.90

3.73

umol/l

—

Gout, unspecified

184

1.09

0.09

1.0

1.2

1.97

3.15

umol/l

1.95

156

Chronic suppurative otitis media, including avohilmo

223

1.08

0.09

1.1

1.4

5.28

5.05

umol/l

0.12

202

Exclusion endpoint for supernumerary teeth

1.09

0.09

1.0

1.7

4.28

5.98

umol/l

—

Social disorders starting during childhood or adolescence

1.05

0.08

1.2

1.5

3.65

5.87

umol/l

—

Chronic tubulo-interstitial nephritis

1.05

0.08

3.5

1.3

3.07

4.40

umol/l

—

Fracture of shoulder and upper arm

926

0.97

0.08

1.4

1.3

4.77

5.16

umol/l

0.40

821

Peripheral artery operations in Hilmo

107

1.12

0.08

1.0

1.3

2.91

3.24

umol/l

0.20

Fracture at wrist and hand level

109

1115

0.97

0.08

1.4

1.3

4.37

5.43

umol/l

2.67

981

Use of interferon beta-1a

1.09

0.08

1.6

1.2

6.99

5.92

umol/l

—

Accidental poisoning by and exposure to alcohol

1.08

0.08

1.0

1.1

6.51

6.56

umol/l

—

Obstructed labour due to maternal pelvic abnormality

352

1.05

0.08

1.2

1.4

3.43

3.74

umol/l

0.24

312

Poor fetal growth

875

0.97

0.08

1.3

5.49

6.13

umol/l

1.29

795

Chronic Coagulation defects

1.03

0.08

2.0

1.1

7.59

5.64

umol/l

—

Parkinson's disease, including avohilmo

127

1.10

0.07

1.6

1.4

3.35

2.62

umol/l

0.70

109

Malignant neoplasm of ovary

1.03

0.07

1.4

1.6

3.58

3.96

umol/l

—

Antepartum haemorrhage, not elsewhere classified

501

1.04

0.07

1.3

5.54

5.67

umol/l

0.09

448

Benign neoplasm: Ascending colon

157

1.08

0.07

1.0

1.4

3.80

3.29

umol/l

0.29

133

Open wound of head

141

1350

0.98

0.07

1.3

4.42

4.96

umol/l

1.10

123

1184

Mental and behavioural disorders due to use of other stimulants, including caffeine

1.12

0.07

1.4

1.2

5.22

6.45

umol/l

—

Long labour

142

1180

1.02

0.06

1.3

5.31

5.63

umol/l

0.51

131

1057

Tooth eruption problems

123

1163

1.02

0.06

1.4

1.3

6.20

6.50

umol/l

0.36

106

1065

Liveborn infants according to place of birth

0.88

0.06

1.4

1.3

3.80

4.86

umol/l

—

Myocardial infarction, strict

374

0.96

0.06

1.1

1.2

1.72

3.41

umol/l

9.58

318

Tumor necrosis factor alpha inhibitors

601

1.03

0.06

1.3

1.4

4.45

5.56

umol/l

1.69

536

Ulcerative ileocolitis

102

0.88

0.06

1.3

1.2

4.19

5.79

umol/l

—

Lung diseases due to external agents

148

1.08

0.06

1.9

1.3

3.85

3.95

umol/l

0.05

129

Other demyelinating diseases of the central nervous system

121

0.91

0.06

1.5

1.3

5.24

5.40

umol/l

0.05

112

Viral conjunctivitis, including avohilmo

119

1.09

0.06

1.2

4.04

5.83

umol/l

1.08

107

HSIL lesion of the cervix uteri, vagina or vulva

112

1141

0.98

0.05

1.3

5.63

5.64

umol/l

0.02

102

1027

Coxarthrosis, primary

698

1.02

0.05

1.2

1.3

2.84

2.98

umol/l

0.14

610

Mandibular retrognathia

316

1.04

0.05

1.6

1.4

3.79

5.93

umol/l

3.38

288

Antenatal screening

141

800

0.99

0.04

1.2

1.3

6.32

6.07

umol/l

0.37

132

725

Other juvenile arthritis

239

1.05

0.04

1.6

1.4

5.66

5.82

umol/l

0.07

217

Juvenile arthritis (FINNGEN)

261

0.96

0.04

1.6

1.4

5.66

5.87

umol/l

0.09

237

Heart failure and bmi 25plus

278

1.03

0.04

1.1

1.2

2.73

3.07

umol/l

0.28

237

In situ neoplasms

108

1096

0.99

0.03

1.2

1.3

4.91

4.80

umol/l

0.11

978

Malignant neoplasm of skin, including Hilmo

566

1.02

0.03

1.4

2.57

3.59

umol/l

3.05

494

Fracture of femur

288

1.03

0.03

1.5

1.3

4.75

3.57

umol/l

0.71

253

Inguinal hernia

123

827

0.99

0.03

1.1

1.3

3.96

4.89

umol/l

1.98

101

712

Single delivery by caesarean section

155

875

1.01

0.03

1.3

5.74

6.12

umol/l

0.61

146

793

Status post-ami

172

0.97

0.01

1.1

1.3

1.73

3.08

umol/l

2.14

140

Toxic effect of ethanol

106

0.94

0.01

1.6

1.1

5.73

6.47

umol/l

—

Gout, idiopatic and unspecified

246

0.98

0.00

1.0

1.3

2.36

3.20

umol/l

1.22

205

Other complications of labour and delivery, not elsewhere classified

104

916

1.01

0.00

1.1

1.3

6.65

6.26

umol/l

0.65

832

Presence of other devices

362

1.01

0.00

1.2

1.3

2.55

4.15

umol/l

4.12

320

Alzheimer’s disease (Late onset), excluding more controls

1.05

0.00

1.0

1.1

2.61

1.94

umol/l

0.71

Toxic effect of contact with venomous animals

101

0.99

0.00

1.8

1.4

5.37

5.68

umol/l

—

Additional codes for the location of defect, injury or illness

124

0.97

0.00

1.4

1.3

3.63

5.26

umol/l

1.30

109

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

148

1.01

0.00

1.4

1.3

2.31

4.73

umol/l

4.63

130

Dislocation, sprain and strain of joints and ligaments of elbow

232

0.99

0.00

1.1

1.4

7.17

5.48

umol/l

1.13

208

Type1 diabetes, definitions combined, early onset

386

1.01

0.00

1.5

1.4

4.61

5.63

umol/l

1.73

344

Other diseases of arteries and capillaries

144

0.97

0.00

1.3

4.19

4.51

umol/l

0.14

125

HSIL lesion of the cervix uteri

109

1089

1.00

0.00

1.3

5.64

5.72

umol/l

0.07

981

Primary Sclerosing Cholangitis, IBD and UDCA required

0.89

0.00

1.0

1.4

2.84

5.10

umol/l

—

Common variable immunodeficiency

0.00

0.0

1.1

—

8.35

—

Dextrocardia

0.00

0.0

1.2

—

4.12

—

Lupus nephritis

0.00

-0.00

0.0

1.2

—

6.75

—

Haemolytic disease of fetus and newborn

0.00

-0.00

0.0

1.8

—

4.50

—

Excessive and redundant skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

6.86

—

Amputation

0.91

-0.00

1.0

1.2

2.16

3.20

umol/l

—

Spina bifida

0.00

-0.00

0.0

2.6

—

8.94

—

Ulcer of vagina/vulva

0.97

-0.00

1.1

6.13

6.45

umol/l

—

Fall involving playground equipment

1.00

-0.00

2.0

1.9

4.30

4.02

umol/l

—

Congenital hydrocephalus

0.00

-0.00

0.0

1.2

—

7.25

—

Congenital heart conduction disorder

0.00

-0.00

0.0

1.3

—

4.10

—

Eclampsia

0.00

-0.00

0.0

1.2

—

6.78

—

Pregnant state, incidental

0.00

-0.00

0.0

1.0

—

7.70

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

0.00

-0.00

0.0

1.2

—

7.91

—

Vertical strabismus

0.87

-0.00

2.0

1.4

4.03

5.72

umol/l

—

Qualitative platelet defects

0.00

-0.00

0.0

1.2

—

4.81

—

Cachexia

0.00

-0.00

0.0

1.0

—

5.66

—

Non-Hodgkin lymphoma, all, including Hilmo

150

1.00

-0.00

1.1

1.3

1.84

3.71

umol/l

5.11

129

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS